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SUMMARY 
Cardiac morphogenesis is a complex process governed by evolutionarily conserved transcription 
factors and signaling molecules. The Drosophila cardiac tube is linear, made of 52 pairs of 
cardiomyocytes (CMs), which express specific transcription factor genes that have human 
homologues implicated in Congenital Heart Diseases (CHDs) (NKX2-5, GATA4 and TBX5). 
The Drosophila cardiac tube is linear and composed of a rostral portion named aorta and a 
caudal one called heart, distinguished by morphological and functional differences controlled by 
Hox genes, key regulators of axial patterning. Overexpression and inactivation of the Hox gene 
abdominal-A (abd-A), which is expressed exclusively in the heart, revealed that abd-A controls 
heart identity. The aim of our work is to isolate the heart-specific cis-regulatory sequences of 
abd-A direct target genes, the realizator genes granting heart identity. In each segment of the 
heart, four pairs of cardiomyocytes (CMs) express tinman (tin), homologous to NKX2-5, and 
acquire strong contractile and automatic rhythmic activities. By tyramide amplified FISH, we 
found that seven genes, encoding ion channels, pumps or transporters, are specifically expressed 
in the Tin-CMs of the heart. We initially used online available tools to identify their heart-
specific cis-regutatory modules by looking for Conserved Non-coding Sequences containing 
clusters of binding sites for various cardiac transcription factors, including Hox proteins. Based 
on these data we generated several reporter gene constructs and transgenic embryos, but none of 
them showed reporter gene expression in the heart. In order to identify additional abd-A target 
genes, we performed microarray experiments comparing the transcriptomes of aorta versus heart 
and identified 144 genes overexpressed in the heart. In order to find the heart-specific cis-
regulatory regions of these target genes we developed a new bioinformatic approach where 
prediction is based on pattern matching and ordered statistics. We first retrieved Conserved Non-
coding Sequences from the alignment between the D.melanogaster and D.pseudobscura 
genomes. We scored for combinations of conserved occurrences of ABD-A, ABD-B, TIN, PNR, 
dMEF2, MADS box, T-box and E-box sites and we ranked these results based on two 
independent strategies. On one hand we ranked the putative cis-regulatory sequences according 
to best scored ABD-A biding sites, on the other hand we scored according to conservation of 
binding sites. We integrated and ranked again the two lists obtained independently to produce a  
final rank. We generated nGFP reporter construct flies for in vivo validation. We identified three 
1kb-long heart-specific enhancers. By in vivo and in vitro experiments we are determining 
whether they are direct abd-A targets, demonstrating the role of a Hox gene in the realization of 
heart identity. The identified abd-A direct target genes may be targets also of the NKX2-5, GATA4 
and/or TBX5 homologues tin, pannier and Doc genes, respectively. The identification of 
sequences coregulated by a Hox protein and the homologues of transcription factors causing 
CHDs, will provide a mean to test whether these factors function as Hox cofactors granting 
cardiac specificity to Hox proteins, increasing our knowledge on the molecular mechanisms 
underlying CHDs. Finally, it may be investigated whether these Hox targets are involved in 
CHDs. 
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Homeotic transformations 
The mutant fly with four wings and no halteres was first identified by Calvin Bridges in Thomas 
Hunt Morgan laboratory in 1915 (Figure 1). 
 
 
Figure 1. 
 
This now famous little "monster" was a starting point for Edward Lewis in his research 
on homeotic transformations. In 1978, Lewis published his work on the bithorax complex 
(Lewis, 1978; Lewis; 1998). In this paper he reviewed a series of Drosophila mutations that 
affect the thoracic and abdominal segmental identities. These mutations were called “homeotic” 
(from the greek homoios or “similar”) because one single mutation transforms a whole segment 
into another (towards an anterior one). Remarkably, the different homeotic mutations mapped to 
the third chromosome in an order that corresponds to the anterior to posterior order of the 
segments in which they act. These collinear genes responsible for the anterior to posterior 
patterning along the body axis are now called Hox genes, because they share a 180bp sequence 
called “homeobox”, which encodes a 60 amino acids DNA-binding domain called 
“homeodomain”. Still more astonishing was the fact that these genes are evolutionarily 
conserved in function and organization from Hydra to Homo. In the genome of Drosophila, there 
are two clusters called Antennapedia and bithorax, both located on chromosome III. Mammals 
possess 39 Hox genes ordered in four clusters that reflect their temporal order of expression 
during embryogenesis and along the anterior-posterior (AP) axis (Figure 2). This means that the 
genetic control mechanisms of body planning have been preserved roughly unchanged through 
650 million years of evolution. (reviewed in Lawrence and Morata, 1994; Carroll, 1995; Carroll, 
2005; Maeda & Karch, 2006; Iimura & Pourquie, 2007). 
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Figure 2 (modified from Pearson et al., 2005). Hox expression and genomic organization in 
Drosophila melanogaster and Mus musculus. The diagram on the left shows a stage 13 
Drosophila embryo colored to indicate the approximate domains of expression for all 
Drosophila Hox genes except proboscipedia (pb), which is not expressed in the embryo. The 
segments are labeled: Md, mandibular; Mx, maxillary; Lb, labial; T1-T3, thoracic segments; A1-
A9, abdominal segments. The diagram on the right shows a mouse embryo at embryonic day 
12.5, with the approximate Hox expression domains depicted on the head to tail axis. The 
positions of the hindbrain rhombomeres are labeled R1, R4, R7. In both diagrams, the domains 
of expression of the Hox transcripts are color-coded as the corresponding genes in the Hox 
cluster diagram below. The diagrams below the embryos show the Hox clusters in the genomes 
of Drosophila and mouse with the genes in the order in which they are found in the 
chromosome. Genes are colored to differentiate between Hox paralogous members. Genes that 
are orthologous between clusters and specie are labeled in the same color. The position of three 
non-Hox homeodomain genes zen, bcd and ftz are shown in the fly Hox cluster in grey boxes. 
Gene abbreviations: lab, labial; pb, proboscipedia; zen, zerknullt; bcd, bicoid; Dfd, Deformed; 
Scr, Sex combed reduced; ftz, fushi tarazu; Antp, Antennapedia; Ubx, Ultrabithorax; abd-A, 
abdominal-A; Abd-B, Abdominal-B. Anterior is to the left and dorsal to the top. 
 
 
Hox genes in morphogenesis 
The homeotic function is the trademark by which Hox genes became known. Nevertheless, the 
function of Hox genes is that of regulating morphogenesis and organogenesis. This is the 
function we have to study if we want to answer the question of how differences arise from sets of 
genes so widely shared. 
Hox genes encode homeodomain transcription factors (reviewed in McGinnis, 1994). 
One target of Hox genes are Hox genes themselves. To control organogenesis, Hox proteins act 
at a local cellular level within the segment they specify and regulate groups of target genes. The 
Hox protein function here is to get integrated into an enhanceosome at a given moment of 
development and confer AP positional information to this enhanceosome (Castelli-Gair Hombría 
& Lovegrove, 2003). Garcia Bellido (1977) coined the term “realizator genes” to describe these 
sets of genes subordinated to Hox control that mediate segment-specific morphogenesis. 
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Hox target genes 
As Capovilla et al. stated in their 1994 paper: “Understanding how genes of the HOM/Hox 
family control morphogenesis requires the identification and characterization of their target 
genes [...]. Yet very little is known about the nature of these target genes and their roles in 
segment-specific morphogenesis.” 
 There are characteristics inherent to Hox genes that make the identification and 
characterization of their target realizators difficult. To start with, almost all Hox proteins bind in 
vitro to a short core consensus 5'-TAAT-3' sequence. This sequence occurs in the genome 
approximatively every 1 kilobase. In vitro promiscuous binding is very common and in 
consequence, of all the in vitro detected binding sites most have no in vivo significance (Ekker et 
al., 1991, 1992). Second, Hox protein action may not be cell autonomous, acting through 
signaling cascades which can in turn lead to effects outside the Hox expression domain. This is 
the case where the Hox gene abd-A activates only the target gene rhomboid (rho) in the C1 cell 
lineage to promote the differentiation of oenocytes in the dorsal ectoderm (Brodu et al., 2002). 
At another level, in some tissues and organs, Hox genes have overlapping expression domains 
and cross-regulate each other, therefore the target may require inputs from multiple Hox genes. 
For example, the activities of the Hox genes Ubx and abd-A are integrated at the decapentaplegic 
(dpp) visceral mesoderm enhancer, where UBX acts as an activator and ABD-A as a repressor 
by binding to the same sites in the sequence (Capovilla et al., 1994; Capovilla and Botas, 1998). 
UBX and ABD-A instead appear to act both as repressors of the limb promoting target gene 
Distal-less (Dll) apparently also binding through the same HOX binding sites (Gebelein et al., 
2004). Moreover, the control region of the putative target may be far from the transcription unit 
of the target gene, and thus difficult to find. 
 In spite of all these experimental difficulties, a few Hox target genes (direct or indirect) 
are known, although the exact number is still a matter of debate. A direct target provides 
compelling evidence that a specific Hox protein is binding to a specific enhancer in vivo 
(Mahaffey, 2005; Pearson et al., 2005). The definitive demonstration that a given gene is a direct 
target of a given HOX is the mutation of the HOX binding sites of its enhancer towards BICOID 
(BCD) binding sites. Bcd is not a Hox gene and its protein binds to a different consensus site 
than Hox proteins. HOX can be made to bind to this BCD site by changing only one amino acid 
in their homeodomain (Treisman et al., 1992; Schier & Gehring, 1992). So, if BCD sites are 
introduced in place of the HOX sites and the enhancer looses activity, and if a compensatory 
mutation in the Hox protein, allowing it to bind to the mutant BCD site, restores the activity of 
the enhancer, we are sure that that HOX transcription factor binds in vivo to the enhancer 
sequence of the given gene. Nevertheless, such rigorous test has only been performed in four 
cases: to demonstrate that dpp is a direct target of Ubx (Capovilla et al., 1994) and of abd-A 
(Capovilla and Botas, 1998), that apterous is a direct target of Antp (Capovilla et al., 2001), and 
that the intronic sequence of Hoxa-4 is regulated by Ubx when assayed in Drosophila (Haerry & 
Gehring, 1997). 
Moreover, most of the known targets are either transcription factors or signaling 
molecules, therefore not true realizators. On the other hand, we still have little or no knowledge 
of targets regulated at the same time and in the same place by the same Hox protein. Finding 
groups of co-regulated direct target realizator genes within similar cell types during development 
will help us assess the question of how is it that a Hox gene triggers specification, differentiation 
and organogenesis. From a broader point of view, Hox-dependent regulatory networks will help 
us to understand how these master genes create cell diversity in order to make serial structures 
different.  
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HOX specificity 
There are only eight Hox genes in Drosophila and probably thousands of realizator genes in 
order to make and organ. How do Hox proteins selectively regulate such broad spectrum of 
target genes? The segments in Drosophila share plenty similarities so one could think that 
similar sets of target genes are shared by different Hox proteins or by different combinations of 
Hox proteins. But if we think the number of target genes in a co-regulated set is variable from 
one in the precursors of Keilin’s organs (Vachon et al., 1992) or the oenocytes (Brodu et al., 
2002) to possible more than a hundred in the halteres (Akam, 1998; Weatherbee et al., 1998), we 
then realize such explanation does not account for so many clear morphological differences that 
are Hox-dependent.  
On the other hand, at the protein level, Hox proteins bind to DNA through the 
homeodomain. The three alpha helices that conform the homeodomain are shared by all these 
transcription factors (Gehring et al.,1994, Mann, 1995). Moreover, Hox proteins (except for 
ABD-B) have indistinguishable in vitro binding sites. Then, how is HOX functional specificity 
achieved in vivo? How do individual Hox proteins selectively activate or repress target gene 
expression? 
 HOX specificity appears to depend on several non-exclusive mechanisms. One 
possibility is that the binding of a cofactor to a Hox protein confers the selectivity (and higher 
affinity of the Hox protein for its target). Unfortunately, only a couple of HOX cofactors 
constituted by extradenticle (exd) and Homothorax (Hth), the homologs of mammalian PBX and 
MEIS proteins respectively (Moens & Selleri, 2006), have been identified to date (Chan et al., 
1994; Mann & Affolter, 1998; Ryoo et al., 1999). On the other hand, many processes involving 
the function of Hox genes have been found to be exd-independent (Pinsonneault et al., 1997; 
Galant et al., 2002). The failure of traditional genetic and biochemical screens to identify new 
HOX cofactors suggests that Hox genes might not always function exactly how we previously 
expected. This view is reinforced by the recent and unforeseen finding that Hox and segment-
polarity genes cooperate to control Dll expression. Thus, another possibility is that Hox proteins 
collaborate (cooperate and/or recruit sets of activators and repressors) with other transcription 
factors to control gene expression. Collaboration does not imply a physical interaction between 
the transcription factors integrated in the enhanceosome (Walsh & Carroll, 2007). In other 
words, a combination of different proteins including one or more HOX would regulate 
transcription. In fact, there is an expanding pool of transcription factors that are putative 
collaborators in the modulation of Hox target genes. Some evidence comes from the 
collaboration between UBX and SMADs in the selective repression of the target gene spalt (sal) 
in the Drosophila haltere disc (Walsh & Carroll, 2007). Furthermore, new insights on target 
selection come from the way a Hox protein binds to the DNA structure. Recent experiments 
suggest that Hox proteins recognize “generic” binding sites through the homeodomain-major 
groove interactions while the N-terminal arm and the linker residues would select among these 
sites by “reading” the structure and electrostatic potential in the minor groove (Joshi et al., 
2007). 
 
A new model for old questions 
From all the mentioned characteristics of Hox genes and Hox proteins it is evident that their 
functions are difficult to analyze. Since the 1980s new techniques have been developed and with 
them new questions regarding Hox genes have been raised. Instead, the number of model 
systems to assess Hox function and HOX specificity has remained mainly the same and new ones 
need to be introduced. Cardiogenesis in Drosophila constitutes such a system.  
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The Drosophila cardiac tube 
The embryonic cardiac system of Drosophila is formed by a simple linear tubular structure at the 
dorsal midline below the epidermis of the embryo and it is called “dorsal vessel” or “cardiac 
tube” (Campos-Ortega & Hartenstein, 1997). Just like the vertebrate primitive cardiac tube, the 
Drosophila dorsal vessel presents AP polarity (Lo & Frasch, 2003). The anterior portion of the 
tube is called “aorta” and the posterior one “heart” (Figure 3). The heart is the autonomous 
beating organ (Wessells et al., 2004) that pumps the haemolymph (“insect blood”) in a posterior 
to anterior manner (Rizki, 1978), comparable to the direction of blood flow in the vertebrate 
primitive cardiac tube (Forouhar et al., 2006). In the fly open circulatory system, the 
haemolymph reenters the heart through valve-like cells named ostia (Rizki, 1978).  
 
 
 
Figure 3 (modified from Campos-Ortega & Hartenstein, 1997). Dorsal view of the cardiac 
tube of an embryo at the end of embryogenesis. The dorsal vessel extends from segment T1 
(not shown in the diagram) to segment A7. Alary muscles (al) attach the dorsal vessel to the 
apodemes. The dorsal vessel, consisting of the heart posteriorly (middle of segment A4 to 
segment A7) and the aorta anteriorly (segment T1 to middle of segment A4), is formed by 
cardiomyocytes (ca), in association with a bilateral row of pericardial cells (pc). In its anterior 
portion, the cardiac tube is flanked by the lymph glands (lg) and the ring gland (rg). 
Abbreviations: brain, br; supraoesophageal commissure, sec; posterior spiracle, sp; thoracic 
segment, t; abdominal segment, a. 
 
The formation of the cardiac tube 
The dorsal vessel, like the somatic and visceral musculature and the fat body, has mesodermal 
origin. The mesoderm is derived from the most ventral cells of the blastoderm (Campos-Ortega 
& Hartenstein, 1997). The cells of the mesoderm express twist (twi) and later snail (sna), both 
encoding transcription factors. twi, in turn, activates tinman (tin), the gene encoding a 
homeodomain transcription factor of the NK class (reviewed in Ruiz-Gomez, 1998). At 
gastrulation, these cells invaginate along the ventral furrow and spread dorsally to form a 
monolayer beneath the ectoderm. During dorsal migration important regulatory events that will 
ultimately lead to specification of heart progenitors are triggered (Frasch, 1999). The 
cardioblasts become specified thanks to inductive signals that come from the neighbouring 
ectoderm (Zaffran & Frasch, 2002), which comprehend the cascades of the signaling factors dpp 
and wingless (wg), homologous to the vertebrate BMP and WNT molecules in vertebrates, 
respectively. Upon spreading of the mesoderm beneath the ectoderm, the mesoderm utilizes the 
pattern information from the ectoderm to acquire its distinct dorsal-ventral polarity. dpp 
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transmits dorsal positional information from the ectoderm to the mesoderm (Frasch, 1995; 
Lockwood & Bodmer, 2002). A consequence of dpp function is the restriction of tin expression 
to the dorsal mesoderm (Frasch, 1999) and possibly the induction of pannier (pnr), encoding a 
Zinc finger transcription factor (Klinedinst & Bodmer, 2003). As development proceeds, wg 
plays a key role in segmental regulation in cooperation with sloppy paired (slp) (Lee & Frasch, 
2000). 
The cells from the dorsal-most edge of the mesoderm form the so-called mesodermal 
crests on either side of the embryonic germ band. The heart progenitors derive from segmentally 
restricted clusters of cells from the dorsal mesodermal crests (Campos-Ortega & Hartenstein, 
1997) (Figure 4). The presumptive heart progenitors rearrange and the clusters come into 
contact. These cells undergo a mesenchymal-epithelial transition and as a result of these 
movements, two rows of cells on either side of the embryo are formed: a dorsal row of 
cardioblasts and a ventrally adjacent row of pericardial cells (Fremion et al., 1999) (Figure 4). 
 
 
 
Figure 4 (from Campos-Ortega & Hartenstein, 1997). Embryonic heart development. (A) 
Stage 11 embryo showing segmentally restricted clusters of cells from the dorsal mesoderm, 
which will give rise to the heart progenitors. (B) Stage 13 embryo where the heart progenitors 
rearrange and the clusters come into contact after mesenchymal-epithelial transition. Two rows 
of cells on either side of the embryo are formed: a dorsal row of cardioblasts and a ventrally 
adjacent row of pericardial cells. (C) Stage 17 embryo where the two rows of cardioblasts meet 
and fuse at the dorsal midline to form the dorsal vessel, which becomes a hollow tube. 
 
During germ band elongation the two rows of cardioblasts meet and fuse at the dorsal 
midline to form the dorsal vessel, which becomes a hollow tube extending from the first thoracic 
segment (T1) to seventh abdominal segment (A7) (Figures 3 and 4). At this moment, upon 
dorsal closure, all the differentiation programs have already been triggered so that the 
cardioblasts become cardiomyocytes. Part of these differentiation programs are activated by tin 
and pnr (Gajewski et al., 2001). Two differentiation transcription factors activated by tin and pnr 
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are muscle enhancer factor 2 (mef2) (Gajewski et al., 2001) and the basic helix loop helix 
transcription factor dHand (Han & Olson, 2005).   
The mature cardiac tube is constituted by 52 pairs of cardiomyocytes, which become 
connected by adherent junctions. The dorsal vessel becomes surrounded in the thorax by the 
lymph glands (of mesodermal origin) and the ring gland (of ectodermal origin) and also by 
loosely arranged, non-myogenic pericardial cells (thought to act as stationary macrophages) 
(Rizki, 1978). The cardiac tube is attached to the dorsal ectoderm by seven pairs of alary muscles 
(Figure 3). As Drosophila is a holometabolous insect, this morphogenetic patrimony will remain 
the same until metamorphosis when all the structures will be eliminated or remodeled (Monier et 
al., 2005). 
 
Anterior-posterior organization of the dorsal vessel 
Like the primitive heart tube in vertebrates, the mature cardiac tube of Drosophila presents 
morphological and functional axial differentiation. Anterior to posterior polarity is manifested 
not only in the subdivision of the dorsal vessel into the two domains, aorta and heart 
(intersegmental polarity), but also, within each segment that forms the cardiac tube 
(intrasegmental polarity) (Ponzielli et al., 2002; Lo et al., 2002).   
Rostral-caudal polarity can be observed within each segment that forms the cardiac tube. 
Each segment is composed of six pairs of cardiomyocytes. The four most anterior pairs of cells 
of each segment that forms the cardiac tube express the gene encoding the homeodomain 
transcription factor tin (Bodmer, 1993). In addition to tin, the two most anterior pairs of cells 
express the transcription factor ladybird (lb) (Jagla et al., 1997). The two most posterior pairs of 
cells within each segment express the gene encoding the transcription factor seven up (svp), the 
Drosophila homolog of the COUP-TF orphan receptors (Lo & Frasch, 2001).  
Moreover, as mention previously, the entire dorsal vessel presents two distinct domains: 
an anterior one (from segment T1 to middle of segment A4) termed “aorta” and a posterior one 
(from middle of segment A4 to segments A7) called “heart” (Rizki, 1978) (Figure 3). The heart 
portion of the cardiac tube presents a wider diameter and lumen compared to the aorta (Ponzielli 
et al., 2002). The three pairs of svp-expressing cells of the heart differentiate into valve-like cells 
called ostia, which allow the inflow of haemolymph into the cavity (Lo & Frasch, 2001). The 
tin-expressing cardioblasts of the heart differentiate into strong contractile beating 
cardiomyocytes, which propel this hemolymph, through the aorta, into an open circulatory 
system in a caudal to rostral direction (Molina & Cripps, 2001). Thus, the aorta constitutes the 
outflow tract of the fly cardiac tube. The SVP- positive cells of the aorta do not differentiate into 
functional ostia and the TIN-positive cells of this domain differentiate into cardiomyocytes that 
are smaller and poorly contractile compared to those of the heart (Ponzielli et al., 2002). 
The correlation between Hox expression domains and axial polarity of the dorsal vessel 
prompted several laboratories to study the possible involvement of Hox genes in cardiac 
diversity. Four Hox genes were found to be expressed in the cardiac tube. Antp is expressed in 
the anterior portion of the aorta, Ubx in the posterior portion of the aorta, and abd-A is expressed 
in all the cells of the heart except in the last four cells where Abd-B is expressed (Figure 5). 
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Figure 5 (from Ponzielli et al., 2002). Rostral-caudal polarity in the Drosophila cardiac tube. 
The diagram shows the expression of the Hox gene Antp and the three genes of the bithorax 
complex (Ubx, abd-A and Abd-B) along the AP axis of the dorsal vessel. Anterior is to the left. 
The black arrows indicate the direction of the haemolymph flow. 
 
In the quintuple mutant Scr-, Antp-, Ubx-, abd-A-, abd-B-, all cardioblasts adopt anterior 
thoracic cardiac cell identity (i.e., cardiomyoblasts that express Antp) and thus no posterior aorta 
cardiomyocytes and heart cardiomyocytes differentiate. Antp affects svp expression. Loss of 
Antp leads to a loss of svp expression in the first pair of abdominal cardiomyocytes, while 
ectopic Antp expression activates svp expression ectopically in the thorax (Perrin et al., 2004). 
Abd-B is known to be a repressor of myogenesis (Michelson, 1994). Early overexpression 
of Abd-B in the mesoderm inhibits cardiogenesis. Consistently, in loss of function experiments 
for this gene, the cardiac tube is formed by 116 cells instead of the wild-type number 104 (Lo et 
al., 2002). 
The double mutant Ubx-, abd-A- embryos phenocopy the quintuple mutant, that is, there 
is no cell diversity along the AP axis of the cardiac tube, indicating the crucial requirement of 
these two genes in the control of thoracic versus abdominal cell identity during early stages of 
cardiac development (Ponzielli et al., 2002). 
In Ubx loss of function embryos, the cells of the posterior aorta (segments A1 to middle 
of segment A4), where Ubx is normally expressed, have some defects in polarization and 
pericardial cells of this domain are disorganized. On the other hand, the heart of Ubx loss of 
function embryos is similar to that of wild-type embryos. Ectopic expression of Ubx impairs 
morphology of the heart cardioblasts and the ostia do not become functional (Ponzielli et al., 
2002). 
In abd-A loss of function embryos, the cells of the heart are transformed into posterior 
aorta-like cells (i.e., those cells which express Ubx) and thus ostia function and heartbeat are not 
observed in living embryos (Figure 6). Ectopic expression of abd-A transforms the aorta 
morphologically and physiologically into heart (Ponzielli et al., 2002; Figure 6). Thus, abd-A 
controls heart identity. 
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Figure 6 (from Ponzielli et al., 2002). Control of heart identity by abd-A. (A) Expression of 
Hox genes in a wild-type embryo. (B) Transformation of the heart into aorta in an abd-A- 
embryo. (C) Transformation of the aorta into heart in an embryo overexpressing abd-A 
(UAS>abd-A).  
 
 
How does abd-A control heart identity? 
Hox genes encode transcription factors, so in order to control morphogenesis they regulate 
downstream effector genes. These effector genes can be other transcription factors, signaling 
molecules or realizator genes. In order to find out which are the Hox target realizator genes and 
in order to determine if these are direct or indirect targets we need to find and study the cis-
regulatory sequence of such genes. 
Three genes, Ndae1, Ih and Ork1 have been found to be expressed in the TIN-positive 
cells of the heart portion of the cardiac tube (Perrin et al., 2004; Monier et al., 2007). These 
encode channel proteins: Ndae1 encodes a Na+ driven anion exchanger belonging to the NBC 
family (Romero et al., 2000), Ih encodes a Na+/K+ hyperpolarization activated channel belonging 
to the HCN family, and Ork1 a two pore domain K+ channel (Perrin et al., 2004; Monier et al., 
2007). The latter one, is involved in heart rate and heartbeat activities in the fly (Lalevée et al., 
2006) and Ih possibly generates the cardiac pacemaker If or Ih currents (Occor et al., 2007). 
Thus, these genes constitute part of the realizators of the heart. Moreover, these genes have 
concomitant expression to that of abd-A in wild-type as well as in gain and loss of function 
experiments (Perrin et al., 2004). To find the heart cis-regulatory sequences of these putative 
abd-A target realizator genes constitutes the main aim of our project. The importance of 
understanding how realizator genes are regulated in normal heart development will help us 
understand the mechanisms underlying Congenital Heart Diseases (CHDs) From these 
experiments we will also gain insight on Hox specificity during development. 
 
A 
B 
C 
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The late role of abd-A and Ubx in cardiogenesis 
There is only indirect evidence, from loss and gain of function experiments, for the role of abd-A 
as an activator of putative target genes such as Ndae1, Ih and Ork1. The possible role of Ubx as a 
repressor in late cardiogenesis comes from the observation of a slight loss of heart expression of 
Ndae1 (Perrin et al., 2004), Ih and Ork1 (Bruno Monier, Laurent Perrin and Michel Sémériva, 
unpublished) upon ectopic expression of Ubx. Therefore, in such embryos the loss of expression 
of the target genes in the heart may be due to the forced posterior expression of the repressor. On 
the other hand, in the same embryos, the target genes may be activated by normal presence of 
abd-A. In wild-type embryos, abd-A normally represses Ubx. In abd-A- embryos, Ubx is de-
repressed posteriorly, and therefore the lack of expression of the target gene in these mutant 
embryos could be due either to repression of Ubx or to lack of activation by abd-A. Given the 
fact that abd-A and Ubx are involved in lineage specification at earlier stages of cardiogenesis 
(Perrin et al., 2004), it is not possible to asses the expression of putative target genes in double 
mutant Ubx-, abd-A- embryos, since these embryos lack cardiomyocyte diversity and all the cells 
of the cardiac tube resemble those cells of the anterior aorta that normally express Antp (Perrin et 
al., 2004). 
 We designed one experiment to resolve this issue. UAS>abd-AHx are flies that carry an 
inducible mutated hexapeptide variant of abd-A (Merabet et al., 2003) capable of inducing 
normal lineage choice in early cardiogenesis and repressing Ubx in the heart. Such protein 
variant does not lead to ectopic expression of the putative target gene Ih (BM, LP and MS, 
unpublished). We propose here to study in vivo the late role of abd-A and Ubx in the 
activation/repression of realizator genes by assaying expression in embryos which bear the 
UAS>abd-AHx transgene in a double mutant Ubx-, abd-A- background. Such embryos will lack 
Ubx and abd-A expression but will have appropriate early lineage specification and thereby 
abdominal cardiomyocytes will be formed. Nevertheless, the abdominal cardiomyocytes will 
acquire posterior aorta morphology. A lack of Ih expression in these embryos indicates a late 
role of abd-A as an activator, since in these double mutant embryos the repressor function of Ubx 
is absent. 
 
A core network of transcription factors to develop a heart 
Although abd-A controls heart identity, it does not account alone for the regulation of a myriad 
of target genes that are needed to form a heart and that are also expressed in other tissues or 
organs. Indeed, heart development is governed by a core network of evolutionarily conserved 
transcription factors (Olson, 2006; summarized in Figure 7). 
 The first gene to play a role in mesodermal subdivisions encodes the homeodomain 
transcription factor TIN (Bodmer, 1993). In tin mutants the heart fails to form (Bodmer, 1993; 
Azpiazu & Frasch, 1993), but on the other hand, overexpression of tin does not cause ectopic 
heart induction (Yin & Frasch, 1998; Lockwood & Bodmer, 2002). Nkx2-5 is the vertebrate 
homologue of tin, but it does not rescue completely the phenotype of tin mutants (Park et al., 
1998; Ranganayaculu et al., 1998). Nevertheless, the repression function of the protein is 
equivalent in late stages of development (Zaffran et al., 2006) meaning that some of their 
functions during heart development have diverged while others have been conserved.  
 pnr (Ramain et al., 1993; Winick et al.,1993), encoding the ortholog of the vertebrate Zn-
finger GATA-4 transcription factor (Gajewski et al., 1999), is expressed only in the cardiogenic 
region during mesoderm differentiation where it mediates dpp signaling and acts in concert with 
tin (Klinedinst & Bodmer, 2003). In pnr mutant embryos, tin expression is dramatically reduced 
in the clusters that correspond to the cardiac precursors (Klinedinst & Bodmer, 2003). Ectopic 
expression of pnr can only activate early mesodermal ectopic expression of tin, meaning that pnr 
is insufficient to maintain tin expression later on (Klinedinst & Bodmer, 2003). Like NKX 2-5 
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and GATA-4 in vertebrates, TIN and PNR act synergistically (Durocher et al., 1997) to activate 
differentiation genes like D-mef2 (Gajewski et al., 2001) and dHand (Han & Olson, 2005).   
 Possibly the oldest of these core heart transcription factors is the MADS-box protein 
MEF2 (Olson, 2006). Vertebrates have three different mef2 genes (Potthoff & Olson, 2007) 
while there is only one in Drosophila. The single mef2 gene in Drosophila (D-mef2) is expressed 
in all muscle lineages (Nguyen et al., 1994; Lilly et al., 1994), thus it is expressed in all the 
cardiomyocytes. D-mef2 mutant embryos have proper heart specification but cardioblasts fail to 
differentiate and contractile protein genes fail to be activated (Lilly et al., 1995). Recently, it has 
been demonstrated that D-mef2 activates its targets in a temporal dose-dependent manner (Elgar 
et al., 2008). 
 dHAND is a basic helix-loop-helix transcription factor that, like D-mef2, is a direct target 
of tin and pnr during cardioblast differentiation (Han & Olson, 2005). dHand is expressed in all 
the cardiomyocytes, pericardial cells as well as in the haematopoietic precursors of the lymph 
glands (Kolsch & Paululat, 2002; Han & Olson, 2005). dHand mutant embryos display abnormal 
cardiac morphology and a deficient number of pericardial cells is observed (Han et al., 2006). 
HAND factors are also involved in vertebrate cardiogenesis (Yamagishi et al., 2001). Moreover, 
human Hand genes rescue Drosophila dHand mutant embryos, suggesting an evolutionarily 
conserved role of these factors in mammalian cardiogenesis (Han et al., 2006). 
 The TBX family of transcription factors is also necessary to build a heart. There are eight 
T-box genes in the Drosophila genome. Five of them, Dorsocross 1-3 (Doc) (Reim et al., 2003, 
2005), H15 and midline (mid) (Miskolczi-McCallum et al., 2005; Qian et al., 2005; Reim et al., 
2005) are expressed in the cardiac tube. The three Doc genes are expressed in the svp-expressing 
cells of the heart (Reim & Frasch, 2005) while H15 and mid are expressed in all the 
cardiomyocytes of the cardiac tube (Miskolczi-McCallum et al., 2005; Qian et al., 2005; Reim et 
al., 2005). Doc2 and Doc3 mutants display severe defects in cardiac cell specification as shown 
by the absence of multiple markers for the cardioblast population (Reim & Frasch, 2005). Doc 
interacts with tin and pnr in cardiac cell specification (Reim & Frasch, 2005). Ectopic expression 
of Doc in conjunction with tin and pnr results in cardioblast differentiation, suggesting these 
three factors act synergistically during dorsal vessel development (Reim & Frasch, 2005), just 
like the vertebrate TBX20 directly interacts with NKX2-5 and GATA factors (Stennard et al., 
2003). 
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Figure 7. Cardiac expression of transcription factors involved in cardiac development. (A) 
Diagram representing the cardiac tube divided in aorta and heart. Below are shown the domains 
of expression of Ubx and abd-A. (B) The colored horizontal bars indicate the domains of 
expression in the cardiac tube of the transcription factors indicated to their right. On the right 
column are indicated the vertebrate homologs of the fly genes. 
 
 All these transcription factors involved in heart development bind to DNA through 
characteristic binding sites. The binding site of a given transcription factor can be represented in 
the form of a Positional Weight Matrix (PWM). A PWM is a matrix that is created from a 
collection of in vitro footprints of a given RNA or DNA-binding protein. Such biding sites are 
aligned, and a score is assigned to the probability of occurrence of a certain base in a certain 
position (Hertz & Stormo, 2002). In this way, binding sites that slightly diverge from the 
consensus sequences can be also represented. Due to the sequencing of Drosophila genomes and 
the availability of information of the sequence of binding sites of many transcription factors, it is 
possible to assess through bioinformatic methods the presence of putative in vivo binding sites of 
transcription factors in a given DNA sequence (Stormo, 2000; Osada et al., 2004). In the past, in 
vitro inmunoprecipitation experiments were used to look for putative in vivo binding sites of a 
transcription factor to the DNA sequence of a putative target gene. For example, the visceral 
mesoderm enhancer of dpp was found by inmunoprecipitating a genomic fragment containing 
the enhancer with the Hox protein Ubx (Capovilla et al., 1994). Bioinformatic tools allow to 
assess the presence of a number of transcription factor binding sites simultaneously and 
moreover to assess their spatial distribution in order to determine if such transcription factor 
binding sites form a cluster which could stand in vivo for a cis-regulatory motif of a given gene 
(Halfon et al., 2002; Markstein et al., 2002; Grad et al., 2004; Berman et al., 2004). Using 
bioinformatic tools, the binding sites of the mentioned evolutionarily conserved transcription 
factors in the core network can be found in the sequence of the heart realizator genes. 
 In first instance, we analyzed through bioinformatics if the binding sites of these 
conserved transcription factors are present in the putative cis-regulatory sequences of the 
putative abd-A target genes expressed in the heart portion of the cardiac tube. We looked for 
conserved clusters of binding sites of the mentioned transcription factors that might be forming 
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part of the enhanceosome regulating realizator gene expression in the heart. On second place, we 
are currently studying which of these transcription factors might cooperate or collaborate in vivo 
with abd-A in the regulation of the putative Hox heart targets in order to realize a heart with its 
morphological and physiological distinct cell types. As some of the human homologues of these 
transcription factors are involved in congenital heart diseases (in particular, NKX2-5, TBX5 and 
GATA4) the identification of the cis-regulatory sequences of their target genes may help 
elucidate what are the molecular abnormalities of the altered proteins in the patients and help 
device eventual therapeutic strategies. 
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MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
A. Bioinformatics 
 
The bioinformatic approaches applied in this project have been developed through time as more 
informatic tools evolved from 2004 to present. All bioinformatic procedures applied here are the 
product of a collaboration with experts in this research area (David Martin and Bruno Zeitouni at 
the IBDML of CNRS in Marseille, France; Stein Aerts at the Laboratory of Neurogenetics, Dept. 
of Molecular and Developmental Genetics, University of Leuven, Belgium). 
 
 
1 - First bioinformatic approach based on available online tools 
Most methods used up to 2004 identified cis-regulatory sequences from interspecies sequence 
comparison. They identified Conserved Non coding Sequences (CNSs), operationally defined as 
islands of non coding sequence with relatively high conservation flanked by regions of low 
conservation and assumed that this conservation reflected regulatory function (Bergman et al, 
2002). The benchmark set by the new toolkits developed in 2004 was that of searching for 
conserved clusters of known transcription factor binding sites within conserved regions of the 
Drosophila genome.  
The sequence of a given transcription factor binding site is expressed as a Positional 
Weight Matrix (PWM). The source of the PWMs in this boinformatic approach is 
FlyReg/pollard [http://rana.lbl.gov/~dan/matrices.html]. These PWMs were created by Dan 
Pollard (Eisen’s Lab) from a DNAseI footprint database. The PWMs used from this database are 
those of the following proteins: DMEF-2, TIN, GATA, TBX, UBX. We used the UBX PWM 
instead of the ABD-A one because the former was more precise (i.e., was created from a larger 
set of DNAseI footprints) and in any case UBX and ABD-A bind in vitro to the same sequences 
(Capovilla et al., 1994).  
 For the transcription factor SVP, which was absent in the mentioned database, and no 
footprints were available in literature, we created a PWM de novo from a few published binding 
sites of the SVP vertebrate homolog COUP-TF.   
 In 2004, Berman et al. published the eCIS-ANALYST toolkit, which searches in the 
Drosophila melanogaster and Drosophila pseudoobscura genomes conserved clusters of 
Transcription Factor (TF) Binding Sites (BSs). More information about how this tool works can 
be found at http://rana.lbl.gov/cis-analyst/. At the same time, were published the VISTA tools 
(Frazer et al., 2004), which are a comprehensive suite of programs and databases for 
comparative analysis of genomic sequences. More information about this toolkit can be found at 
http://genome.lbl.gov/vista/index.shtml. We used the VISTA Browser to retrieve CNSs between 
the gene of interest in the D. melanogaster genome and its orthologue in the D. pseudoobscura 
genome sequence and to visualize these CNSs in an alignment.  We also used rVISTA (Loots et 
al., 2002) to search for conserved clusters of TF BSs. 
 A third approach, based always on the same principle, was the one we set up in 
collaboration with Dr. David Martin (unpublished). This method applied two strategies. One 
strategy was to look first throughout the D. melanogaster gene of interest for TF BSs using 
PWMs. We took the genomic sequence including the query gene from the previous Computed 
Gene (CG) to the next one. In a second step, we aligned this sequence to the orthologue in D. 
pseudobscura, using pre-computed global alignments. We then tested if the TF BS score fell into 
CNSs. A second strategy of this same approach was designed to circumvent the problem that a 
few conserved bases inside a non-conserved region of the genome might be missed in the general 
alignment. We manually introduced in the previously aligned sequence all TF BSs found 
previously. This allowed us to distinguish aligned sites from conserved sites. We also allowed 
the program to find TF BSs that slightly deviated from the consensus (i.e., we changed the p-
value during the scoring step). Moreover, with this method we could analyze different 
percentages of sequence identity (i.e., 50% conservation and 70% conservation). 
 The outcome of these three tools used - eCIS-ANALYST, VISTA and our own - were 
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merged and compared in order to give the selected regions the priority to be cloned. The 
overlapping was made taking the query gene sequence aligned (either to the D. pseudobscura or 
the D. virilis orthologue) and manually drawing all the different outputs. We did not use any 
statistical methods. 
 
 
2 - Second bioinformatic approach based on a novel pattern matching based 
method 
Throughout the last three years, our collaborators in Dr. Semeriva's lab found seven genes to be 
differentially expressed in the heart portion of the cardiac tube, through a candidate gene 
approach (Monier et al., 2007). Moreover, recently, they undertook a genome-wide approach to 
gain more knowledge on the heart transcriptome. They performed microarray experiments 
comparing the larval heart transcriptome with that of the aorta. With this experiment, 144 genes 
were found to be overexpressed in the heart with respect to the aorta. These constituted a new set 
of putative downstream target genes under specific abd-A regulation. Following these new 
results came the necessity to improve our bioinformatic methodology for heart cis-regulatory 
discovery. 
 
Summary 
 
A pattern matching based approach was used to search for motifs with PWMs of known TF BSs 
in CNSs. This approach consists of two strategies, which we named A and B.  
In strategy A, we first searched for the CNSs with the best multiple high-scoring ABD-A 
BS. We then looked for clusters of BS of heart TFs except ABD-A. The same two searches were 
applied to the CNSs of D. pseudoobscura. We then integrated these results and produced a first 
scoring ranking which is after refined in a final ranking according to the presence of at least three 
high scoring TF BSs besides that of ABD-A. We called this last ranking list “TopA”.  
Instead in strategy B, we first searched the best CNSs with clusters of BSs of heart TFs 
(ABD-A included). We did this separately for the D. melanogaster and D. pseudoobscura CNSs. 
We kept the CNSs with the best motif conservation score from alignments.  Then, we integrated 
the results for CNSs of both species and produced a ranking which we called “TopB” list.  
We posteriorly overlapped and ranked the lists TopA and TopB to produce a final list 
containing the best 20 scores that we called “Top20”. For these best 20 putative Cis-Regulatory 
Modules (CRM) we used Toucan to draw inside each of them the predicted binding sites. 
 
 
Our new approach in detail 
 
We used a pattern matching based approach to search for motifs with PWMs of known TF BSs 
in CNSs. This approach consists of two strategies, which we named A and B. Our first gene 
dataset from which we started off to validate the approach was composed of 7 genes, expressed 
in the heart and not in the aorta, which were found by candidate gene approach (Na+ driven 
anion exchanger 1: Ndae1; Ca++ channel protein β subunit: Ca-β; Ih channel: Ih; Calcium 
ATPase at 60A: CaP60A; Open rectifier K+ channel 1: Ork1; seizure: sei; painless: pain) and 2 
genes (Dro-myosupressin: Dms and CG15537) found in the microarray data analysis to have the 
highest fold change expression in the heart compared to the aorta. The expression of these latter 
two genes was further corroborated through fluorescent in situ hybridization. 
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This is our first gene set:  
 
 CG4675  (Ndae1) 
 CG6320  (Ca-β) 
 CG8585  (Ih) 
 CG3725  (Ca-P60A) 
 CG1615  (Ork1) 
 CG3182  (sei) 
 CG15860  (pain) 
 CG15537  (CG15537) 
 CG6440  (Dms) 
 
We then decided to cover all the intergenic region to avoid the problem of missing regulatory 
elements distantly positioned with respect to the transcription unit of the gene. We delimited the 
regions containing the query gene plus 20kb upstream and 20kb downstream the transcription 
unit. We aligned these sequences to their corresponding orthologues in the D. pseudobscura 
genome using SLAGAN and we retrieved all CNSs using CNScan (Bruno Zeitouni, 
unpublished). The CNSs retrieved match the following parameters: 
 
                            - 65% identity, 100bp windows 
                            - not exons 
                            - not UTR 
 
 
We obtained 386 CNSs. We then decided to extend the CNSs with flanking sequence so that 
they are minimally 300bp long because it is generally acknowledged that an enhancer element is 
around 300-1000 bp. For example, the cardiac tube enhancer of dHand is 300 bp (Han  & Olson,  
2005) as the dSur cardiac tube enhancer (Akasaka et al.,  2006; Hendren et al., 2007). 
Since VISTA only returns the D. melanogaster sequences of the CNSs, the D. 
pseudoobscura sequences are obtained from the UCSC “net” alignments 
(http://genome.ucsc.edu/index.html?org=D.+melanogaster) 
 In strategy A, we first searched for multiple high-scoring ABD-A BSs within the CNSs. 
For doing this, we used MotifLocator 
(http://homes.esat.kuleuven.be/~thijs/help/help_motiflocator.html) with the ABD-A PWM from 
FlyReg/pollard (http://rana.lbl.gov/~dan/matrices.html) using a threshold of 0.8. From the output 
we retained the top 3 scoring hits for each CNS. We then scored each CNS according to the 
formula: 
 
 
! 
cnsscore PMWscore
1
3
"  
 
 
CNSs were then ranked accordingly. The same scoring method is used to score and rank 
the D. pseudobscura CNSs found for these genes. We integrated these ranks using order 
statistics as described in Aerts et al. (2006). The second step of strategy A was to find clusters of 
BSs of TFs known to be involved in heart development. Below are listed the selected TFs and 
the source from where the corresponding PWM was taken. The website addresses are cited at the 
end of the list. 
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 ABD-B (from Pollard matrices) 
 NKX25.01 (high affinity, from TRANSFAC): homologous to the D. melanogaster TIN 
 NKX25.02 (low affinity, from TRANSFAC): homologous to the D. melanogaster TIN 
 GATA (from TRANSFAC): orthologous to the D. melanogaster PNR 
 MEF2A (MADS box, from Jaspar): homologous to the D. melanogaster D-MEF2 
 SRF (MADS box, from ClusterBuster ): homolog to the D. melanogaster D-MEF2 
 TBX core motif "GGTGT" (from Gosh et al., 2001): same binding site than the  
       D. melanogaster  TBX factors H15, MID and DOC (Frasch lab, unpublished). 
 EBOX (CANNTG): orthologous to the D. melanogaster dHAND 
 
*TRANSFAC: http://www.biobase-international.com/pages/index.php?id=transfac 
*Jaspar: http://jaspar.genereg.net/ 
* ClusterBuster: http://zlab.bu.edu/cluster-buster/cbust.html 
 
We then used ClusterBuster setting the gap parameter at 20 and the motif threshold equal 
to 6 in order that predicted motifs will have relative high specificity and thus reduce the number 
of false positives. We ranked all CNSs of D. melanogaster according to the ClusterBuster score. 
We treated D. pseudobscura CNSs in the same way and finally we integrated these rankings 
using order statistics. We then integrated the ABD-A ranking obtained in first place to that 
obtained with ClusterBuster ranking and again using order statistics, we obtained an overall 
ranking from these previous two. We then selected those sequences with clusters with binding 
sites for a minimum 3 different PWMs excluding ABD-A and from these we selected the top 30 
best scored in the overall ranking. We called these 30 predictions “TopA”. 
 In strategy B, we first looked for clusters of binding sites for all the above mentioned 
PWMs, including ABD-A. For this, again, we used ClusterBuster, but we ranked them according 
to the CNS score as defined in strategy A. We treated the CNSs obtained from D. pseudobscura 
in the same way. Once more, we integrated these rankings using order statistics. In a second step 
we looked at the evolutionary conservation of the binding sites in a cluster. We retrieved all the 
binding sites found in D. melanogaster CNSs. From a LAGAN alignment of each CNS we 
retrieved all the aligned sequence in D. pseudobscura and looked for the binding sites of D. 
melanogaster in these aligned sequences. If the D. pseudobscura aligned site was of the same 
length as that of D. melanogaster, we counted the number of identical nucleotides. The sum of 
all conserved base pairs within all binding sites of a cluster constituted our conservation score. 
We ranked separately all the CNSs of D. melanogaster and D. pseudobscura according to this 
conservation score and we integrated the obtained rankings with order statistics. In the same way 
as we had done in strategy A, we selected those CNSs with clusters of binding sites containing a 
minimum of three different PWMs including ABD-A and from these we selected the top 30 best 
scored in the overall ranking. We called these 30 predictions “TopB”.  
 We then proceeded to integrate the “TopA” and “TopB” lists according to order statistics 
thus creating a final “Top20” list with the best 20 putative CRMs. We used Toucan 
(www.esat.kuleuven.be/~saerts/software/toucan.html) to draw inside each of these 20 CNSs the 
binding sites predicted to be in each CRM. 
 For in vivo validation of these CRMs we arbitrarily selected further parameters as 
follows:  
 
1) distance of the putative CRM to the transcription start site 
2) quality and quantity of the TF BSs found in the CRM: 
      - number of ABD-A sites (the more the better) 
- at least a TIN site and a MEF2 site 
- spatial configuration of the BS inside the cluster  
3) GO annotations 
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For cloning of the predicted CRMs, whenever possible, CRMs belonging to same gene were 
cloned into the same construct in order to reduce the amount of transgenic flies and increase the 
number of predictions validated. Further details of the transgenic reporter constructs selected for 
in vivo validation are explained in “Results”. 
 
 
Application of this novel approach using as dataset co-regulated genes differentially 
overexpressed in the heart found through microarray experiments: 
 
After in vivo validation of this “Top20”, we applied the same strategy using as initial dataset 
those genes found to be differentially expressed in heart with respect to the aorta through the 
microarray experiments. The initial dataset contains 144 significant differentially expressed 
genes ranked according to their expression Fold-Change (FC) in the heart with respect to the 
aorta. Dms and CG15537 are first in the FC ranking. From this new enlarged dataset we obtained 
a list of 40 CRMs, which we called “Top40”. Further details of the transgenic reporter constructs 
selected for in vivo validation are explained in “Results”. 
 
 
B. Cloning 
 
The molecular biology techniques described below have been adjourned from “Molecular 
Cloning” (Sambrook et al., 1989). 
To obtain the fragments to be cloned, either restriction or polymerase chain reaction 
(PCR) methods were used according to the availability of restriction sites present in the fragment 
of interest. 
  
1 - Vectors used 
 
The vectors used for this project are: 
 
Blue/white selection vectors 
 
   pBluescript KS+ (Stratagene) 
   pUC19 
   
Transformation reporter vectors 
 
   CHAB (Capovilla et al.,1994) 
    pStinger (Barolo et al., 2004) 
   pH-Stinger (Barolo et al., 2004) 
 
2 - Polymerase Chain Reaction (PCR) 
 
  Primer design 
 
For amplification by PCR, primers were designed using the Invitrogen online tool “OligoPerfect 
Designer” (http://www.invitrogen.com/content.cfm?pageid=9716). 
 To each primer, we added a restriction site not present in the fragment to be amplified, 
but present in the polylinker of the vector, to enable ligation of such fragment to the vector. 
 Afterwards, primers were checked for primer-dimers and secondary structure using the 
online tool “Oligo Calc” (http://www.basic.northwestern.edu/biotools/oligocalc.html). 
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  PCR reactions 
 
The DNA polymerase used in all reactions is KOD XL polymerase (Novagen), a proofreading 
enzyme isolated from the extreme thermophile Thermococcus kodakaraensis KOD1, which 
possesses superior processivity and fidelity that enables faster and more accurate PCR 
amplification than that which can be achieved with conventional enzymes, including Pfu DNA 
polymerase.  
The thermocycler used in every case is Px2 Thermal Cycler (Thermo Scientific). 
 
3 - Restriction Reactions 
 
Restrictions with the appropriate restriction enzyme/s were carried out using one unit of enzyme 
for each microgram of DNA in the restriction buffer recommended by the company in a final 
volume according to the amount of DNA to be cut. Each restriction was carried out at 37oC for at 
least one hour.  
 
4 - Purification of vector and insert 
 
Restricted vectors were always purified from TAE 1% agarose gel using the QIAquick Gel 
Extraction Kit (QIAGEN). The same procedure was utilized for inserts when we had not 
obtained a unique PCR product. Instead, inserts where only the desired PCR product had been 
obtained where restricted and purified using the QIAquick Gel Extraction Kit without loading 
them on gel.  
 
5 - Ligation 
 
The nanograms of insert to put in the ligation reaction are the product of the proportion in size of 
insert to vector by the nanograms of vector by the excess number of molecules of insert with 
respect to vector, according to the following formula: 
 
 (kb of insert : kb  of vector) x ng of vector x 5-10 (excess number of molecules) = ng of insert 
 
 The mixture with the appropriate amounts of insert and vector was heated up at 65oC for 
20 minutes. An equal volume containing a mix of the T4 ligase and buffer (Takara Ligation kit) 
was added to the mixture. This final ligation mixture was incubated for at least one hour at 18oC. 
 
6 - Transformation 
 
The plasmids constructed were transformed into Calcium-competent cells of the Escherichia coli 
DH5α strain lacking ampicillin resistance. 
 Bacterial cells were incubated on ice with the DNA of interest for 30 minutes. 
Transformation was performed by heatshock at 42oC for 1 minute and subsequent incubation on 
ice for 5 minutes. Recovery of the cells and resistance expression were allowed by shaking the 
cells in 1ml of Luria Broth  (LB) for 20 minutes.   
 Recovered cells were plated on LB agar plates containing 100 µg/ml of ampicillin.  
 
7 - Minipreps 
 
Screening of the colonies was done using Qiagen miniprep protocol (http://www1.qiagen.com), 
without column purification. 
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8 - Midipreps 
 
Amplification of the quantity of the plasmid of interest was done growing 50ml of plasmid-
containing bacterial culture and purifying the DNA with the QIAgen tip100 midiprep kit. In 
every case, the DNA was resuspended in 100 µl of TE (10mM Tris-HCl pH 7.5, 1mM EDTA). 
 
9 - Glycerol stocks 
 
Long-term conservation of the plasmid of interest at -80oC was achieved by adding 1 ml of 50% 
sterile glycerol to 0.5 ml of midiprep cell culture.  
 
C. Transgenesis 
 
 1 - Preparation of DNA for injection 
 
The midiprep DNA to be injected was centrifuged for 20 minutes to eliminate any insoluble 
particles that might have remained, which could clog the needle. The supernatant was transferred 
to a new tube and quantified with the spectophotometer.  
 The plasmids to be injected bear a transformation vector containing a P element and were 
co-precipitated with the so called “helper plasmid” (pIChIID2-3, Ken Irvine, personal 
communication) bearing the transposase necessary for the integration of the P element and thus 
of the construct of interest into the Drosophila genome. The construct to be injected was mixed 
with helper plasmid in a ratio 6:1 (12 ug +2 ug) and co-precipitated in a final volume of 50 µl by 
addition of 0.3M NaOAc and 2.5 volumes of absolute ethanol.  
 After centrifugation the pellet was washed in 70% ethanol for 3 minutes and resuspended 
in 20 ml of injection buffer (5mM KCl, 0.1mM NaPO4, pH 6.8). The DNA was recentrifuged, 
transferred to a clean new tube and only 2 µl were loaded into a Femptoneedle.  
 
 2 - Egg laying and preparation of the embryos to be injected  
 
  Egg laying 
 
The flies were put to lay in cages on a molasses agar medium (see Appendix). Flies were 
submitted to a normal photoperiod, thus eggs were usually laid from the beginning of the 
afternoon until late in the evening.  
 As the transformation vectors used carry the mini white gene, the strain of flies used for 
egg laying were mutant for this gene. This strain is w1118 carrying a deletion of the whole 
endogenous white gene.  
 
  Dechorionation, dissection and alignment of the embryos 
 
Embryos were recovered from the molasses agar plate with a brush and washed with milliQ  
water. Dechorionation of the embryos was done using 40% bleach for 1 minute, followed by 
washing with milliQ water.  
 After dechorionation, embryos were aligned on a piece of agar plate with the same 
anterior to posterior direction for 7-10 minutes, since embryos must be injected before 
blastoderm cellularization, a developmental stage that begins 45-50 minutes after eggs are laid at 
22°C. Then embryos were transferred to a double-sticky tape on a coverslip. The embryos 
aligned on the coverslip were put to dessicate for 4 minutes in a chamber containing silica gel. 
After dessication, embryos were covered with Halocarbon oil, and the coverslip was placed on a 
slide under a Nikon SMZ 645 microscope, as shown in figure 8 below.  
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The injector used was an Eppendorf Femtojet Easy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Diagram of embryos to be injected. The posterior part of the embryo, where the 
needle is introduced is towards the anterior part of the slide. 
 
  Treatment of the embryos after injection 
 
The slide with the injected embryos covered with oil was placed on a molasses agar plate and 
covered with a lid to keep the necessary humidity. The humid chambers were placed at 18oC 
until the eclosion of the larvae 48 hours later.  
 
  Isolation of transformants 
 
First instar larvae were collected from the humid chamber and out of the oil to be placed in a 
food vial containing a drop of fresh yeast. The vial was placed at 25oC. At this temperature, after 
10 to 12 days the new adults emerged from the pupae and were crossed individually to flies of 
the strain  w1118  in order to evidence in the next generation the presence of the transgene bearing 
the w+ gene and thus the transformants (colored eyed flies) obtained from injections.  
 The sucessive treatment given to transformants is described on this same chapter 
“Materials and Methods” under the subtitle “Fly Genetics”. 
 
 
D. Fly Genetics 
 
Summary of symbols 
 
♀ :  female 
♂:  male 
w-: white strain w-1118   
Hmz: homozygote 
Htz: heterozygote 
MASS: mass cross 
R!: recombination event  
Gn: generation 
+: wild-type chromosome 
 
Notes: 
 
* The chromosomes of Drosophila are written in the folllowing order: first the X, next the 
second (II) and last the third (III).  Each pair of chromosomes is separated from the other with a 
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semicolon while the homologous are separated by a slash. Different alleles in the same 
homologous are separated by a comma. 
 
* Drosophila males are achiasmatic.  
 
* In every cross and throughout the generations the genotype of interest and to be selected is 
highlighted in yellow. 
 
 
1 - Mapping of transformants 
 
In order to map in which chromosome the transgene landed we crossed a colored eyes male to 
virgin females of the double balancer line SM5/Xa/TM3. SM5 and TM3 are balancer 
chromosomes of the second and third chromosome, respectively. They avoid meiotic 
recombination because they bear inversions. Xa is a translocation between the second and third 
chromosomes with a breakpoint in the gene apterous. SM5 is characterized by the dominant 
marker Curly of Oster (CyO) whose phenotype is Curly wings while TM3 is characterized by the 
dominant marker Stubble (Sb) whose phenotype is short bristles. In G1, males with colored eyes 
(due to the mini w- present in the P-element) and with both balancers will be selected to cross to 
w- females. In this cross the balancer chromosomes will segregate independently from each other 
and the P-element will segregate opposite to the homolog where it is inserted. 
 
 
 
G0                                  ♀  w-/w-; SM5/Xa/TM3          x        ♂  w; P?/+ 
 
 
G1                                 ♂  w/ w-/ Y; SM5/P?/ TM3         x        ♀  w-/w-; +/+; +/+ 
 
 
G2      Possible genotypes and phenotypes obtained depending on chromosome linkage: 
 
      w- / w- or Y;  P/ +; +/ TM3: colored eye flies with Stubble bristles  
      w- / w- or Y;  P/ +; +/ +: colored eye flies 
      w- / w- or Y;  +/ SM5; +/ TM3: white eye flies with Curly wings and Stubble bristles 
      w- / w- or Y;  +/ SM5; +/ +: white eye flies with Curly wings           
 
       or 
                  
      w- / w- or Y;  +/ SM5; P/+: colored eye flies with Curly wings                                     
      w- / w- or Y;  +/ +; P/ +: colored eye flies 
      w- / w- or Y;  +/ SM5; +/ TM3: white eye flies with Curly wings and Stubble bristles 
      w- / w- or Y;  +/ +; +/TM3: white eye flies with Stubble bristles  
 
      or  
 
     P/ w-; +/+; +/+: colored eye females 
     w-/Y; +/+; +/+: white eye males 
 
 
 
 
P 
 on the III 
 
P 
 on the II 
 
P 
 on the X 
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2 - Making balanced stocks of transformants 
 
In order to generate balanced stocks of each transgene, virgin females with genotype w-/w-; 
SM5/P?/TM3 (obtained in the G1 of the mapping cross described above) are crossed to males of 
the same genotype (their brothers) if the P-element insertion maps to the second or third 
chromosome. Instead, if no color eye males where obtained in the G1 of the “mapping cross”, 
the virgin females of the mentioned genotype are crossed to males bearing an X balancer 
chromosome (FM7i). 
 
 
 
A) If the P-element insertion is on the II chromosome: 
 
G0                                ♀♀  w-/w-; P/SM5; +/TM3    x    ♂♂  w w-/w-; P/SM5; +/TM3  
 
G1  (STOCK LINE)          w-/w-; P/ SM5; +/TM3   or   w-/w-; P/ P ; +/TM3  
 
 
B)  If the P-element insertion is on the III chromosome: 
 
G0                              ♀♀  w- /w-; +/SM5; P/TM3       x     ♂♂  w/w-; +/SM5; P/TM3  
 
G1  (STOCK LINE)          w- /w-; +/ SM5; P/TM3   or   w- /w-; +/ SM5; P/P  
 
 
C) If the P- element insertion is on the X chromosome:  
 
FM7i is a w- balancer X chromosome which bears the dominant marker Bar whose phenotype is 
“bar” shape eyes. 
 
G0                          ♀♀  P/w-; +/SM5; +/TM3       x       ♂♂  FM7i/Y; +/+; +/+ 
 
G1                                 ♀♀  P/FM7i                      x     ♂♂  P/Y 
 
G2  (STOCK LINE)                      P/P or Y; +/+; +/+  
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3 - Putting together two insertions that are on the same chromosome 
 
These crosses are done to obtain individuals that carry in the same chromosome two independent 
insertions of the same reporter construct or of two different constructs (e.g., a reporter and a 
UAS construct). In the first case, the aim of this cross was to obtain a stronger signal of the 
reporter construct since individuals with only one copy of the insertion reported a weak 
expression of the transgene. In all the transformants obtained for the Ork1-seq9 reporter 
construct (pMC055), the insertion mapped to the third chromosome. 055-M11 and 055-M9m1 
are the names of two independent transformant lines that were recombined through the following 
crosses: 
 
 
 
G0                     ♀♀  055-M11/055-M11        x        ♂♂  055-M9m1/TM3 
 
*From the progeny of this cross collect darker eye virgins not TM3 
 
G1                       ♀♀ (R!)  +/+; 055-M11/055-M9m1      x     ♂♂  w-/w-; +/+; +/+  
                                                                                        (MASS) 
 
*From the progeny of this cross collect 10 males with very dark eyes. 
*Cross individually these 10 males: 
 
G2                         ♂ 1-10  055-M11, 055-M9m1/+        x      ♀♀  SM5/Xa/TM3 
 
*From this cross collect colored eye males and females that are also SM5 and TM3. 
 
G3  (STOCK LINE)              ♀♀  x  ♂♂  SM5/+; 055-M11, 055-M9m1/TM3  
 
* In paralell to the G2 cross, we crossed individually the two original parental males 
carrying only one insertion:    
 
   ♂  055-M9m1/TM3     x      ♀♀  w-/w-; +/+; +/+                  
 
   ♂  055-M11  (Hmz viable)     x      ♀♀  w-/w-; +/+; +/+  
 
These two parallel crosses were performed in order to allow comparison of the eye color 
between the progeny of G2 and the original parental lines. 
 
 
4 - Putting an allele in a mutant context 
 
In order to analyze in vivo how the heart cis-regulatory sequences identified behave with respect 
to the presence of the Hox gene abd-A, we crossed each reporter construct lines into an abd-A- 
background. For each reporter construct we crossed two independent lines.  
abd-A is located in the third chromosome. abdAM1 (later indicated as abd-A-) is a recessive 
amorph EMS lethal allele and the line we used is balanced with TM6b, a balancer of the third 
chromosome whose markers are Humeral (Hu) in adults and Tubby (Tb) in pupae. TM6bZ carries 
also the Ubx-lacZ marker, which makes β-galactosidase in the Ubx expression pattern. All the 
flies used carry the w1118 mutation on the X chromosome. 
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A) Putting the Ork1 heart enhancer (055) in an abd-A- mutant background through 
recombination: 
 
055-M11 and 055-M9 m1 are the names of two independent transformant lines obtained for 
Ork1-seq9 reporter construct (055). Both lines mapped the insertion to the third chromosome.  
 
G0                           ♀♀  055-M9m1/TM3 
                          or         x               ♂♂  abdA-/TM6b 
          ♀♀  055-M11/055-M11 
        (MASS) 
 
* From this cross collect colored eye virgins not Hu. 
 
G1                          ♀♀  (R!) 055/abd-A-             x            ♂♂  abd-A-/TM6b 
                   (MASS) 
* From this cross collect colored eye Hu males.     
* Cross individually 100 colored eye Hu males. 
 
G2                          ♂1-100  055, abd-A-?/TM6b         x            ♀♀  abd-A-/TM6bZ 
                     
Possible genotypes in the progeny: 
  
 Recombinant genotypes: 
  055, abd-A-/TM6bZ: colored eye flies, TM6b             desired genotype 
055, abd-A-/ abd-A-: lethal 
 Not recombinant genotypes: 
  055/abd-A-: colored eye flies, not Hu 
  055/TM6bZ: colored eye flies, Hu 
 Other genotypes: 
abd-A-/TM6b: white eye flies 
  TM6b/TM6bZ: lethal 
 
If the not-recombinant genotypes were missing in the individual cross, we proceeded to 
make the stock line. 
 
G3    (STOCK LINE)          ♀♀  x  ♂♂    055, abd-A-/TM6bZ 
 
 
B) Putting the Ih heart enhancer in an abd-A- mutant background 
 
For the Ih-seq34 reporter construct (077), we obtained transformant lines that mapped the 
insertion either to the second or third chromosomes. For the line 077-F10, which mapped to the 
third chromosome, we proceeded with the crosses to obtain recombinant individuals in the same 
way as described above for the Ork1 heart enhancer. 
 For the line 077-M2, which mapped to the second chromosome, in order to obtain a final 
stock line with the genotype 077-2M/CyOZ; abdA-/TM6Z containing the two chromosomes of 
interest, we proceeded in the following way. 
 
**Dichaete (D) is a dominant mutation that results in wings extended at 45 degrees from the 
body axis and elevated 30 degrees above and missing the alulae. Lobe (L) is a dominant mutation 
resulting in smaller eyes.  
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 i) We balanced the allele on the second chromosome to the line CyOZ/Xa/TM6bZ: 
 
G0                        ♀♀  077-2M/077-2M; TM3/+     x     ♂♂  CyOZ/Xa/TM6bZ  
                     
*From this cross, collect virgins 077-2M/CyOZ; TM6bZ/+ (Curly wings and Humeral bristles) 
 
G1                         ♀♀  077-2M/CyO; TM6bZ/+ 
 
 ii) In parallel, we crossed the allele on the third chromosome to the line CyOZ/L; 
TM6bZ/D: 
 
G0                       ♀♀  +/CyOZ; abd-A-/TM6bZ    x    ♂♂  CyOZ/L; TM6bZ/D  
 
*From this cross collect males +/L; abd-A-/D (with white Lobe eyes and Diachaete wings, with 
bristles not Humeral) 
 
G1                        ♂♂  +/L; abd-A-/D 
 
 iii) We crossed the differentially balanced lines:  
 
G1                               ♀♀  077-2M/CyOZ; TM6bZ/+     x     ♂♂  +/L; abd-A-/D 
 
*From this cross, collect males 077-2M /L; abd-A-/TM6bZ (with colored Lobe eyes, Humeral 
bristles, not Dichaete or Curly wings) 
 
G2                               ♂♂  077-2M/L; abd-A/TM6bZ       
 
 iv) We rebalanced the males that bear the two alleles of interest: 
 
G2              ♂♂  077-2M/L; abd-A-/TM6bZ        x         ♀♀  CyOZ/Xa/TM6bZ   
 
* From this cross, we collected individuals 077-2M/CyOZ; abd-A-/TM6bZ (with Curly wings and 
Humeral bristles) 
 
G4:  (STOCK LINE)            ♀♀   x   ♂♂  077-2M/CyOZ; abd-A-/TM6bZ 
 
 
 
C) Putting the Dms heart enhancer in an abd-A-  mutant background 
 
For the Dms-seq5 reporter construct (078) we obtained transformant lines that mapped the 
insertion either to the second or third chromosomes. For the line 078-F10, which mapped to the 
third chromosome, we proceeded with the crosses to obtain recombinant individuals in the same 
way as described above for the Ork1 heart enhancer.  For the line 078-M1, which mapped to the 
second chromosome, in order to obtain a final stock line with the genotype 078-M1/CyOZ; abdA-
/TM6Z, we proceeded in the same way as for the line Ih-seq34 reporter construct line 077-M2, 
which also mapped to the second chromosome.  
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5 - Analyzing the heart specific enhancers with respect to the ectopic 
expression of Hox genes 
 
We crossed each reporter construct lines found to drive expression in the heart to flies bearing a 
UAS>abd-A transgene and to flies bearing a UAS>Ubx transgene, to analyze in vivo the behavior 
of heart specific cis-regulatory sequences with respect to overexpression of each one of the Hox 
genes.  
 
The UAS/GAL4 system 
GAL4 encodes a protein of 881 amino acids, identified in the yeast Saccharomyces cerevisiae as 
a regulator of genes induced by galactose. GAL4 activates transcription by directly binding to 
four related 17 bp sites upstream the transcription start site. These sites are termed Upstream 
Activating Sequences (UAS) and function similar to a higher eukaryotic enhancer element. In 
1988, Fischer et al. demonstrated that GAL4 was capable of stimulating transcription of a 
reporter gene under UAS control in Drosophila. GAL4 can be expressed under the control of D. 
melanogaster-specific promoters with little effect upon the organism.  
In 1993, Brand and Perrimon published the development of the UAS/GAL4 system, for 
targeting in vivo gene expression in Drosophila in a temporal and spatial fashion. In this system, 
expression of the gene of interest, the responder, is controlled by the presence of the UAS 
element upstream of the cDNA of interest. Because transcription of the responder requires the 
presence of GAL4, the absence of GAL4 in the responder lines maintains them in a 
transcriptionally silent state. To activate their transcription, responder lines are mated to flies 
expressing GAL4 in a pattern corresponding to the expression pattern of the gene in which the 
GAL4 construct is inserted. Each GAL4 line is called “driver” line. The resulting progeny then 
expresses the responder in a transcriptional pattern that reflects the GAL4 pattern of the 
respective driver (Figure 9). 
 
 
 
Figure 9. (from Duffy, 2002) The bipartite UAS/GAL4 system in D. melanogaster. When 
females carrying a UAS reponder (e.g., UAS>GFP) are mated to males carrying a RE-GAL4 
driver, part of the progeny will carry both UAS>GFP and the RE-GAL4 driver. The presence of 
RE-GAL4 in an alternating segmental pattern in the embryos drives expression of the UAS>GFP 
responder gene in a corresponding pattern (depicted in green). 
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 The UAS/GAL4 ectopic expression system is widely used in D. melanogaster for the 
overexpression of transgenes. The UAS>abd-A and UAS>Ubx transgenes we used are both 
inserted in the second chromosome. The 24B-Gal4 late mesodermal driver (Zaffran et al., 1997) 
was used in all cases to trigger expression in the whole mesoderm. This 24B-Gal4 transgene is 
inserted in the third chromosome.  
 
 
A) Analyzing the Ork1 heart enhancer after ectopic Hox expression (abd-A and Ubx): 
 
We crossed the 055-M11, 055-M9 m1/TM3 recombinants to flies UAS>abd-A and UAS>Ubx. 
We expected the transheterozygote to have concomitant ectopic expression of nuclear GFP 
reporter (nGFP) to that of abd-A, thus abd-A to act as an activator of the target enhancer. We 
expected a reduction of expression of the nGFP signal upon ectopic expression of Ubx, due to 
the possible role of Ubx as a repressor of the target enhancer.  
 
 
 i) Balance the UAS transgene (UAS>abdA and UAS>Ubx) on the second chromosome 
with a lacZ balancer: 
 
G0                         ♀♀  CyOZ/Xa/TM6bZ       x       ♂♂  UAS>abd-A/CyO; TM6b/MKRS 
                 or  
                UAS>Ubx/CyO; TM6b/MKRS 
 
*From this cross collect virgins UAS>abd-A or UAS>Ubx /CyO; TM6b/MKRS (with Curly 
wings and Humeral bristles). 
 
G1                           ♀♀  UAS>abd-A/CyO; TM6bZ/MKRS 
  and  
                      ♀♀  UAS>Ubx/CyO; TM6bZ/MKRS 
 ii) In parallel, cross the reporter on the third chromosome: 
 
G0                       ♀♀  CyOZ/L; TM6bZ/D      x    ♂  +/+; 055-M11, 055-M9 m1/TM3 
 
*From this cross, collect males +/L; III/D (with Lobe eyes and Diachaete wings) 
 
G1                        ♂♂: +/L; 055-M11, 055-M9 m1/D 
 
 
 iii) Cross the progeny of the newly balanced flies: 
 
 
G1                ♀♀:  UAS>abd-A/CyO; TM6bZ/MKRS    x     ♂♂: +/L; 055-M11, 055-M9 m1/D  
               and 
                     ♀♀:  UAS>Ubx/CyO; TM6bZ/MKRS      x     ♂♂: +/L; 055-M11, 055-M9 m1/D  
 
*From this cross collect males UAS>abd-A or UAS>Ubx /L; 055-M11, 055-M9 m1/TM6bZ 
(with Lobe eyes and Humeral bristles) 
 
G2                ♂♂:   UAS abdA/L; 055-M11, 055-M9 m1/TM6bZ 
               and 
          ♂♂  UAS>Ubx/L; 055-M11, 055-M9 m1/TM6bZ 
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 iv) Rebalance the new line containing the two alleles of interest: 
 
G3            ♂♂  UAS>abd-A/L; 055-M11, 055-M9 m1/TM6bZ    x    ♀♀  CyOZ/Xa/TM6bZ 
                        and  
            ♂♂  UAS>Ubx/L; 055-M11, 055-M9 m1/TM6bZ 
 
*From this cross, collect individuals UAS>abd-A or UAS>Ubx /CyOZ; 055-M11, 055-M9 m1/ 
TM6bZ (with Curly wings and Humeral). 
 
G4  (STOCK LINE)       ♀♀    x    ♂♂  UAS>abd-A/CyOZ; 055-M11, 055-M9 m1/TM6bZ 
                                                           and 
             UAS>Ubx/CyOZ; 055-M11, 055-M9 m1/TM6bZ 
 
 v) Cross the new stock balanced lines from G4 to trigger ectopic expression: 
 
G5            ♀♀ UAS>abd-A/CyOZ; 055-M11, 055-M9 m1/TM6bZ  x  ♂♂ +/+; 24BG4/24BG4 
           and 
                 ♀♀  UAS>Ubx/CyOZ; 055-M11, 055-M9 m1/TM6bZ  x  ♂♂ +/+; 24BG4/24BG4 
 
* The embryos of this cross were fixed and stained using both classical immunohistochemistry 
and FISH. The protocols used are described in this chapter of “Materials and Methods” under the 
subtitle “Immunohistochemistry” and “Fluorescent in situ Hybridization”. 
 
B) Analyzing Ih heart enhancer under Hox ectopic expression (abd-A and Ubx) 
 
For the Ih-seq34 reporter construct (077) line 077-F10, which mapped to the third chromosome, 
we proceeded with the crosses in the same way as described above for the Ork1 heart enhancer 
to put the two chromosomes of interest in the same individual and cross the new line to the 24B-
GAL4 driver.  
 For the line 077-M2, which mapped to the second chromosome, in order to obtain a final 
recombinant lines with the genotype UAS>abd-A, 077-M2/CyOZ and UAS>Ubx, 077-M2/CyOZ 
we proceeded in the following way:  
 
 
G0                        ♀♀  077-M2 / 077-M2; +/+     x     ♂♂  UAS>abd-A/CyO; MKRS/Tb 
                                                                                and 
                     ♂♂  UAS>Ubx/CyO; MKRS/Tb 
 
* From the progeny of this cross collect darker eye virgins not CyO. 
 
G1                       ♀♀ (R!)  077-M2/UAS>abd-A    x     ♂♂  w-/w-; +/+; +/+  
                      or          (MASS) 
       ♀♀ (R!)  077-M2/UAS>Ubx       x     ♂♂  w-/w-; +/+; +/+  
 
*From the progeny of this cross collect 10 males with very dark eyes and cross them 
individually. 
 
G2                         ♂ 1-10   077-M2, UAS>abd-A/+       x      ♀♀: CyOZ/L 
                        or 
        ♂ 1-10   077-M2, UAS>Ubx/+ 
 
* From this cross, collect colored eye males and females which are also SM5 and TM3. 
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G3  (STOCK LINE)              ♀♀  x  ♂♂  077-M2, UAS>abd-A/CyOZ 
                                            or 
     ♀♀  x  ♂♂  077-M2, UAS>Ubx/CyOZ 
 
* In paralell to the G2 cross, we crossed individually the two original parental males 
carrying only one insertion, in order to allow comparison of the eye color between the progeny 
of G2 and the original parental lines. 
 
 
  1♂  077-M 2/077-M 2         x      ♀♀  w-/w-; +/+; +/+ 
 
  1♂  UAS>abd-A/CyO         x      ♀♀  w-/w-; +/+; +/+  
 
  1♂  UAS>Ubx/CyO             x      ♀♀  w-/w-; +/+; +/+  
 
G4:            ♀♀  077-M2, UAS>abd-A/CyOZ x  ♂♂  +/+; 24BG4/24BG4 
              or 
                  ♀♀  077-M2, UAS>Ubx/CyOZ  x  ♂♂  +/+; 24BG4/24BG4 
 
* The embryos of this cross were fixed and stained using both classical immunohistochemistry 
and FISH. The protocols used are described in this chapter of “Materials and Methods” under the 
subtitle “Immunohistochemistry” and “Fluorescent in situ Hybridization”, respectively. 
 
C) Analyzing the Dms heart enhancer after Hox ectopic expression (abd-A and Ubx) 
 
For the Dms-seq5 reporter construct (078) line 078-F10, which mapped to the third chromosome, 
we proceeded with the crosses in the same way as described above for the Ork1 heart enhancer 
to put the two chromosomes of interest in the same individual and cross the new line to the 24B-
GAL4 driver. Instead, for the line 078-M1, which mapped to the second chromosome, in order to 
obtain a final stock line with the genotype UAS>abd-A, 078-M1/CyOZ and UAS>Ubx, 078-
M1/CyOZ, we proceeded as for the Ih-seq34 reporter construct line 077-M2 in order to obtain 
recombinant lines and cross them to the 24B-GAL4 driver.  
 
 
6 - Determining the late in vivo role of abd-A during heart development 
 
The following fly crosses where done to gather information on the late role of abd-A during heart 
development. As explained in the Introduction, there is only indirect evidence for the role of 
abd-A as an activator and Ubx as a repressor in late cardiogenesis and this is due to the problem 
that they are also involved in lineage specification at earlier stages of cardiogenesis. To 
overcome this situation we recombined UAS>abd-AHx flies (Merabet et al., 2003) with flies 
carrying the so called “Deficiency 109” (Df109), which removes both abd-A and Ubx. 
UAS>abd-AHx are flies which carry a UAS construct carrying a mutated hexapeptide variant of 
abd-A capable of promoting normal lineage choice in early cardiogenesis and repressing Ubx, 
but does not lead to ectopic expression of the putative target gene Ih (BM, LP and MS, 
unpublished). Df 109 flies carry a deletion on the third chromosome that removes abd-A and Ubx 
simultaneously. Recombinant UAS>abd-AHx, Df109 flies where then crossed to recombinant 
24B-Gal4, Df109 flies. The latter line can force expression of UAS>abd-AHx in the mesoderm 
and is also deficient in abd-A and Ubx. The homozygous Df109 progeny of the cross between 
UAS>abd-AHx, Df109 and 24B-Gal4, Df109 flies have appropiate lineage choice and should 
show the late role of abd-A in the absence of endogenous abd-A and Ubx. 
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A) In order to obtain UAS>abd-AHx, Df109 flies the following crosses were made: 
 
The UAS>abd-AHx flies where courtesy of Y. Graba (LGPD, Marseille, France). UAS>abd-AHx5 
and UAS>abd-AHx21 are two independent lines for which the P-element insertion was mapped to 
the third chromosome. The two independent lines where crossed separately in this experiment.  
Df109 is a deletion on the third chromosome. As abd-A- is a recessive allele the presence 
of the deletion will be detected by the presence of a Ubx haploinsufficient phenotype (big 
haltere). 
 
G0:                                       ♀♀  Df109/TM6b      x       ♂♂  UAS>abd-AHx5 
   or 
                                                                                                  UAS>abd-AHx21 
 
* From this cross collect virgins with bristles not Humeral 
 
G1:      ♀♀  (R!)  Df109/ UAS>abd-AHx     x        ♂♂  abd-A-/TM6b 
              (MASS) 
 
*Cross individually 100 males colored eye males with Humeral bristles and Ubx-. 
 
G2:              ♂1-100  Df109?, UAS>abd-AHx/TM6b     x       ♀♀  abd-A/TM6bZ 
 
*From this cross collect flies that are colored eye, with Humeral bristles and Ubx- phenotype. 
 
G3: (STOCK LINE)                   ♀♀  x  ♂♂  Df109, UAS>abd-AHx/TM6bZ 
 
B) In order to obtain  24B-Gal4, Df109 flies the following crosses were made: 
 
G0                            ♀♀  Df109/TM6b       x        ♂♂  24B-G 
 
* From this cross collect virgins with bristles not Humeral. 
 
G1            ♀♀ (R!)  Df109/24B-G4    x     ♂♂  abd-A-/TM6b      
       (MASS) 
 
*Cross individually 100 males colored eye males with Humeral bristles and Ubx- phenotype. 
 
G2                    ♂1-100  Df109, 24B-G4/TM6b  x      ♀♀  abd-A/TM6bZ  
 
*From this cross collect colored eye, with Humeral bristles and Ubx- phenotype. 
 
G3 (STOCK LINE)                   ♀♀  x  ♂♂    Df109, 24B-G4/TM6bZ 
 
C) In order to obtain UAS>abd-AHx, Df109/24B-Gal4, Df109 embryos the following cross 
was made: 
 
The embryos of the cross below were fixed and stained using both classical 
immunohistochemistry and FISH. The protocols used are described in the chapter “Materials and 
Methods” under the subtitles “Immunohistochemistry” and “Fluorescent in situ Hybridization” 
respectively.  
 
G4                 ♀♀  Df109, UAS>abd-AHx/TM6bZ        x    ♂♂  Df109, 24B-G4/TM6bZ 
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E. Immunohistochemistry 
 
1 - Fixing of embryos 
 
Embryos were collected from the agar plate of the cage with a brush and transferred into a basket 
with a bottom made of nylon mesh. The embryos in the basket were rinsed with water and then 
were dechorionated using 50% bleach for 2 minutes and rinsed again with water. The 
dechorionated embryos on the mesh were immersed in 800 µl of heptane. Fixing was done by 
addition of 300 µl of fix buffer (see Appendix) and 200 µl of 10% formaldehyde to each tube 
with the embryos in heptane. The embryos were left to rotate for 30 minutes. After fixation, 
embryos were devitellinized with 100% methanol, rinsed twice in 100% ethanol and conserved 
at -20oC in 100% ethanol.  
 
2 - Staining of fixed embryos 
 
  Antibody preabsortion 
 
For antibody preabsorption, antibodies were incubated overnight at 4oC in a 1:10 dilution in a 
solution of BBT (see Appendix) with an amount of embryos equal to one fifth of volume of 
antibody added. The antibody was recuperated avoiding the embryos and an equal volume of 
100% glycerol was added to preserve the protein at -20oC. 
 
  Antibody staining 
 
Embryos in 100% ethanol were re-hydrated by washing them for 5 minutes in a solution 1:1 
100% ethanol: PBT (see Appendix). Afterwards, embryos were washed twice in BBT-250 (see 
Appendix) and incubated overnight at 4oC in 500 µl of BBT-250 with preabsorbed antibody 
diluted to a final concentration of 1:1000.  
 The next morning embryos were washed two times ten minutes in BBT-250 and other 
two times ten minutes in blocking solution of BBS-250 (see Appendix). After these washes 
embryos were incubated for 2 hours at room temperature in a BBS-250 solution containing 
preabsorbed biotinylated secondary antibody in a final concentration of 1:500.  
 Following the secondary antibody embryos were washed thrice in 1 ml of PBT and were 
further incubated for one hour in a solution of 500 µl PBT containing avidin and biotinylated 
peroxidase (Vectastain HRP Elite kit, Vectorlabs). This step was required to amplify the signal. 
After incubation, embryos were washed another three times in 1 ml PBT.   
 Embryos staining was done with a solution containing 1 ml PBT, 100 µl DAB (5mg/ml 
in PBS) and 5-10 µl of 0,3% H2O2. Staining was blocked by rinsing in PBT.  
 
  Mounting of stained embryos 
 
Stained embryos in PBT were dehydrated by rinsing them first in 50% ethanol and then in 100% 
ethanol. A posterior wash in methyl salicylate was necessary to digest the yolk, after what the 
salt was rinsed with 100% ethanol. Mounting of the embryos was made on a slide with Canada 
Balsam. Embryos were studied in a Nikon SMZ 645 microscope equipped with Hoffman optics. 
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F. Fluorescent in situ Hybridization (FISH) 
 
Below are schematically described the steps undertaken to perform FISH on embryos : 
 
Hybridization 
 
1) Incubate devitellinized embryos in 500µl 100% ethanol and 500µl xylene for 30 minutes 
2) Wash the embryos five times in 100% ethanol 
3) Wash the embryos twice in methanol 
4) Wash the embryos three times in PBT for five minutes each wash 
5) Inactivate the endogenous peroxidase with: 3% H2O2 (50µl 30% H2O2 + 450µl PBT) in PBT 
washing for 10 minutes  
6) Wash the embryos three times in PBT for five minutes each wash 
7) Postfix embryos by incubating 25 minutes in 4% formaldehyde diluted in PBT 
8) Wash the embryos three times in PBT for five minutes each wash 
9) Incubate embryos at room temperature for 5-10 minutes in 500µl PBT + 1µl 2mg/ml 
proteinase-K 
10) Wash the embryos five times in PBT for five minutes each wash 
11) Postfix embryos by incubating 25 minutes in 4% formaldehyde diluted in PBT  
12) Wash the embryos five times in PBT for five minutes each wash 
13) Wash embryos in 500 µl PBT + 500µl Hybe A for ten minutes 
14) Replace the above solution with 500 µl of Hybe A and wash for 10 minutes 
15) Replace the above solution with 500 µl of Hybe B and prehybridyze in agitation at 55°C for 
1 hour 
16) Replace the above prehybridization solution with 75µl of Hybe B and add 3µl of RNA-DIG 
probe. Hybridize overnight at 55°C without agitation in a water bath. 
________________ 
 
17) Wash embryos three times in 500 µl of Hybe B at 55°C for fifteen minutes each wash 
18) Add 500µl of PBT and place embryos at room temperature 
19) Rinse embryos twice in 1ml PBT 
20) Wash embryos for 5 minutes in 1ml PBT 
21) Wash embryos for 15 minutes in 1ml PBT 
22) Wash embryos for 20 minutes in 1ml PBT 
23) Incubate embryos at room temperature for 1hr in 1:500 biotinylated α-DIG  (preabsorbed at 
1:10) in PBT 
24) Rinse rapidly embryos twice in 1ml PBT  
25) Wash embryos for 5 minutes in 1ml PBT 
26) Wash embryos for 15 minutes in 1ml PBT 
27) Wash embryos for 20 minutes in 1ml PBT 
 
Amplification with the Tyramide StreptAvidin  Biotin System (Perkin Elmer-Life Sciences) 
 
28) Incubate embryos for 30 minutes in TNB 
29) Incubate embryos for 30 minutes in 1:100 SA-HRP in TNB 
30) Wash embryos three times in PBS with 0,1% Triton-X for 5 minutes each wash. 
31) Incubate embryos for 10’ in Tyramide biotinylated (1/50) in amplification solution 
32) Wash embryos three times in PBX for 5 minutes each wash 
33) Incubate embryos for 30 minutes in TNB 
34) Incubate embryos for 30 minutes in 1:100 SA-FITC or SA-TexasRed in TNB 
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Immunofluorescence 
 
35) Wash embryos three times in PBX for 5 minutes each wash 
36) Incubate embryos for 30 minutes in TNB 
37) Incubate embryos with primary antibody/ies overnight at 4°C 
________________ 
 
38) Wash embryos four times in PBS with Triton-X 0,1% for 15 minutes each wash 
39) Saturate embryos by washing 30 minutes in TNB 
40) Incubate embryos with the secondary antibody in TNB, for 1hr at room temperature 
41) Wash embryos four times in PBX for 15 minutes each wash 
42) Mount embryos in a slide with fluoromount media or other mounting media 
 
 
Confocal microscopy 
 
Embryos stained by TSA amplified FISH were analyzed at a Zeiss confocal microscope in order 
acquire only the plane where the heart is observed.  
 
 
G. DNAseI binding assay 
 
In vitro DNAseI binding assays were performed as in Capovilla et al., 1994, using ABD-A and 
UBX proteins. 
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First bioinformatic analysis and in vivo validation for Ndae1 and Ih 
SUMMARY 
We started our project working on three putative Hox target genes: Ndae1, Ih and Ork1. We first 
performed in silico analysis to search for candidate heart cis-regulatory modules of the genes 
Ndae1 and Ih. If this bioinformatic analysis had proven useful after in vivo validation, we would 
have proceeded in the same way to study Ork1. The tools used are described in “Materials and 
Methods: Bioinformatics: First bioinformatic approach based on available online tools”. 
 For each D. melanogaster gene of interest (Ndae1 and Ih) the D. pseudobscura and the D. 
virilis orthologous sequence was retrieved. We used the VISTA Browser to retrieve a map 
containing the Conserved Non coding Sequences (CNSs). rVISTA and eCIS-ANALYST were 
used to search for clusters of Transcription Factor (TF) Binding Sites (BSs). On a further 
instance, we used our own software to visualize TF BSs in an alignment where CNSs were also 
delimited.   
 In every case, we used Positional Weight Matrices (PWMs) to search for TF BSs. The 
PWMs used alone or in combination are: TIN, SVP, GATA, MEF2, TBX and HOX (either UBX 
or ABD-A because they bind to the same sequence in vitro). We did not obtain reliable results by 
overlapping the outputs of all the methods used to predict heart cis-regulatory sequences. 
Nevertheless, the few sequences obtained from overlapping results of bioinformatics (for Ndae1 
only) were given priority to begin cloning experiments and produce transgenic reporter flies. For 
Ndae1, we produced a total of 12 reporter constructs covering the whole gene (Figure 16). Some 
of these constructs overlap. Instead, for Ih, since we did not obtain overlapping bioinformatic 
results, we produced 5 reporter constructs (Figure 21) regarding only conservation blocks 
between D. melanogaster and D. pseudobscura.  
 None of these transgenic reporter flies drove expression in the heart. All the Ih constructs 
reported an expression pattern in embryos (Table 2). Three of the twelve Ndae1 reporter 
constructs did not drive any expression pattern in embryos. Without taking into account the 
overlapping constructs, four Ndae1 reporter constructs drove an expression pattern in embryos 
which corresponds to domains of expression previously described for the endogenous Ndae1 
(Romero et al., 2000; Sciortino et al., 2001) and one construct drove an expression in the 
haemocytes, cells which were not described in previous in situ experiments done for Ndae1.  
 From these results, we concluded that this first bioinformatic analysis needed refinement, 
but all in all, this type of examination can give a general idea of the distribution of BSs for the 
various TFs of interest in the query sequence. On the other hand, using only sequence identity 
between D. melanogaster and D. pseudobscura can give a general view of the enhancer elements 
of a gene, but is not enough when searching for tissue specific enhancers. The bioinformatic 
tools available still needed development and could not substitute immunoprecipitation studies to 
search for cis-regulatory sequences.  
 
 
Bioinformatic results on Ndae1 
The first gene on which we started our bioinformatic analysis was Ndae1. This gene had a 
reliable annotation and its pattern of expression had been published (Romero et al., 2000). First, 
the Ndae1 gene of D. melanogaster was aligned to its orthologues in the D. pseudobscura and D. 
virilis shotgun genomes. Annotation of these latter two genomes had not yet been completed at 
the beginning of 2005, thus the orthologues were retrieved from the database and aligned with 
AVID, using VISTA Browser, a multiple alignment server from VISTA tools. With the same 
software we detected 100 bp to 500 bp CNSs among the three species since we hypothesized that 
short CNSs present in evolutionary related species could stand for regulatory sequences. Figure 
10 shows the output map as shown by VISTA Browser where depicted in pink are the CNSs of 
Ndae1 between D. melanogaster as base genome and the correspondent orthologues in the 
shotgun genomic sequence of D. pseudobscura and D. virilis using a conservation filter of 70%. 
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From this analysis, we deduced that there is a too high degree of sequence homology between 
the aligned sequence of D. melanogaster and D. pseudobscura in order to infer putative cis-
regulatory sequences from CNSs found in the alignments of these two sequences alone. On the 
other hand, there are only three highly conserved (> 70%) CNSs between the aligned sequences 
of D. melanogaster and D. virilis and although this number could be informative, these CNSs are 
very short (< 100 bp) and far away from each other in order to constitute a cis-regulatory module 
by themselves or in combination.  
 
 
Figure 10. Output map of VISTA Browser for the gene Ndae1. Depicted in pink are the 
CNSs of Ndae1 between D. melanogaster as base genome and the correspondent orthologous in 
the shotgun genomic sequence of D. pseudobscura (top row) and D. virilis (bottom row) using a 
sequence identy filter of 70%. In blue are depicted the coding sequences.  
 
 rVISTA (Loots et al., 2002) from the VISTA family of computational tools was used to 
search for conserved clusters of TF BSs. This server allows using user-defined BSs or PWMs to 
scan the sequence of interest, which is loaded as a FASTA file. The conservation filter and the 
window size to scan the sequence may be used as variables. To analyze Ndae1, we used a fixed 
conservation filter of 70% and a variable window size (100 and 500 bp). The usefulness of a 
“non clustering” option is that of evidencing all TF BSs found by the program whether they form 
or not a cluster. To score for TF BSs we used the PWMs described in “Materials and Methods: 
Bioinformatics: First bioinformatic approach based on available online tools” as well as 
combinations of them. The program output distinguishes “aligned sites” from “conserved sites”. 
Aligned sites are those sites that match all nucleotides in an alignment. Conserved sites are those 
sites that fall into conservation regions of the sequence. Figure 11, shows an example of an 
output of rVISTA. In this example Ndae1 sequence was scored for the TIN and SVP BSs. The 
figure shows Ndae1 transcriptional unit using a conservation filter of 70% between the base 
genome of D. melanogaster and the distant orthologous sequence of D. virilis. The window size 
is 100 bp (automatic default window). The figure shows, in the first and second rows, all the TF 
BSs found with these two matrices. In the third and fourth rows, it shows all those BSs that are 
aligned, and in the last two rows those BSs that are also conserved. Notice that only one SVP BS 
inside intron III is conserved across more than 10 kb. 
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Figure 11. Output of rVISTA when Ndae1 sequence is scored for TIN and SVP BSs. The 
figure shows Ndae1 transcriptional unit using a conservation filter of 70% between the base 
genome of D. melanogaster and the distant orthologous sequence of D. virilis. The window size 
is 100 bp (automatic default window). In the first and second rows, all the TF BSs scored with 
TIN and SVP PWMs. In the third and fourth rows, it shows all those BSs that are aligned, and in 
the last two rows those BSs that are also conserved. Notice that only one SVP BS inside intron 
III is conserved across more than 10 kb (pointed with an arrow). In pink are depicted the CNSs, 
in blue the coding exons and in pale blue the 3’ and 5’ UTRs.  
5’
U
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As an example of how we compared the different outputs of a program according to the 
manipulation of the possible variables (e.g., window size or quantity of PWMs loaded), figure 
12 shows part of Ndae1, including intron III and the whole 3' UTR and downstream region, 
allowing a 60% conservation filter between the D. melanogaster and D. pseudobscura 
sequences. This time the sequence was scored for the PMWs of TIN, UBX, MEF2 and SVP 
using a window size of 100 bp. Notice that many more aligned and conserved sites are found. 
Comparing outputs of the same program gave us a better idea of which TF BSs might be 
putatively real in vivo. 
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Figure 12. Output of rVISTA when Ndae1 sequence is scored for TIN, SVP, UBX and 
MEF2 BSs. The diagram shows part of Ndae1, including intron III and the whole 3' UTR and 
downstream region, allowing a 60% conservation filter between the D. melanogaster and D. 
pseudobscura sequences. The sequence was scored using a window size of 100 bp. CNSs are 
depicted in pink and coding exons in blue. 
 
 
 
5’
 
3’
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 Furthermore, in order to compare the outputs of rVISTA with other search methods, we 
performed an analysis using eCIS-ANALYST. Figures 13A, 13B, and 13C show an example of 
the output of this program using the same PWMs (UBX, TIN, SVP and MEF2), a fixed 
minimum number of scored TF BSs per cluster equal to 3 and a variable window size of 100 
(Figure 13A), 500 (Figure 13B) and 1000 (Figure 13C). Notice that there are no clusters when 
the sequence is scored using a window size of 100 and that a conserved cluster between the 
sequence of D. melanogaster and D. pseudobscura is retrieved when using a window size of 
500. Figure 14, shows part of the alignment with the TF BSs found inside this cluster. Notice in 
figure 13C how many more clusters are found only varying the window size. The window size 
variable created us a problem at the time to decide which is the optimal window size to reduce 
false positive results to the minimum. Moreover, the general knowledge we had by then on the 
size (300 -1000 bp) and position of cis-regulatory modules of any given gene did not help us 
overcome this problem. 
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Figure 13. eCIS-ANALYST output score for UBX, TIN, SVP and MEF2 BSs in the whole 
Ndae1 genomic DNA. Parametres: fixed minimum number of TF BSs per cluster equal to 3 and 
a variable window size of 100 (A), 500 (B) and 1000 (C). 
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Another way to tackle the issue of reducing to the minimum false positive results in in 
silico cis-regulatory sequence discovery was to use our own automatic tool. We proceeded in two 
ways. First, we scored in the genome region for TF BSs using PWMs, then we produced an 
alignment with the D. pseudoobscura orthologue and retrieved the CNSs with TF BSs. On 
second place, and to avoid the problem that a few conserved bases inside a non-conserved region 
of the genome might be missed in the general alignment, we introduced manually in the 
previously aligned sequence all TF BSs found on the scoring step. This allowed us to distinguish 
aligned sites from conserved sites. We also allowed the program to find TF BSs that slightly 
deviate from the consensus. Moreover, with this method we could analyze different percentages 
of sequence identity. Figure 14, shows the alignment of part of intron I of D. melanogaster with 
the corresponding D. pseudoobscura ortholog. In this alignment the TF BSs found have been 
introduced by hand. Part of the shown alignment corresponds to eCIS-ANALYST cluster 1 
observed in figure 13B. 
 
 
007238766  --------------------CTTTGCTTCTTG--ATGAAAATATCTTTTAATAAG-----  007238798 INTRON I 
>>>>>>>>>                      |||||||| | |  ||| || |    ||||||  |       <<<<<<<<< 
001372414  GTACTCGTATTTTTGTTGGTCTTTGCTTTTCGTAATGGAACTGCAATTTAATCTGTGCGA  001372473 
 
007238799  ----------------------AAAATGAATATGGTATTGTCAATTTCTTCAAATTCTAA  007238836 INTRON I eCc1 
>>>>>>>>>                        | ||   || |  |  ||    | | | | |    ||   <<<<<<<<< 
001372474  CGTGTTCCAGGTGTCATCTTCCATAAATGATCTAATGGTGGGTGTGTTTACGATCATTAT  001372533 
 
007238837  GGTGTGACTAAAGAGCTGACTACA--------GAACATGTTTAGTGAAAATATATTGAGA  007238888 INTRON I  
>>>>>>>>>    ||    | | ||   || ||||             || || |  | | ||   ||     <<<<<<<<< 
001372534  AATGACGTTTAGGAAGCGATTACATTGTTGCCAGGTTTGGTTTGACACATTAATGTGCAG  001372593 
 
007238889  TACGTGAATTCCATTAGTTATTATAAACCTTTTTGCAAAAGATGATAAAGTATAAGATTT  007238948 INTRON I eCc1 
>>>>>>>>>   |    | || |  ||  ||| |||   ||||||    |   |    |  |||||    |  <<<<<<<<< 
001372594  CAGCAAATTTGCTATAAATATAATACTTCTTTTTTGGGATTCTCTCTATATATAATTAAT  001372653 
 
007238949  ATAGACCTTTAGAGTTTTATTTTAATGCTTGAAAATTACAGGGACAT--------ACCTA  007239000 INTRON I eCc1 
>>>>>>>>>   |  |  |  |  | |  |    ||| | ||  ||||   || || |          ||   <<<<<<<<< 
001372654  TTCAATGTCGATTGGTCAACCGGAATTCATGTGAATTTTGGGCACGTTATCTAGGGTCTT  001372713 
 
007239001  ACAATTTCCAAGAGCAGCCATCAATTAAAAACTTAATATATTGTATGTATGTGTACAAAC  007239060 INTRON I eCc1 
>>>>>>>>>  |   | ||||| |  |    | |  | | | || || |||||  ||  |||   | || |  <<<<<<<<< 
001372714  AGTGTCTCCAAAATAATATTTTATCTGAGAGCTAAACATATTACATTGATGG--AGAAGC  001372771 
 
007239061  TATTTATAAAATATATGGGACGGAATGAATACAATATAGTTTTAATATGTATCAAAAGCA  007239120 INTRON I eCc1 
>>>>>>>>>  | | |          | ||||     ||   |   | ||||   |     || ||||     <<<<<<<<< 
001372772  TTTGTGGGCTTCGAGTAGGACTTTTGGAGAGCTTAAGAGTTCAGAGGCTGATAAAAATAG  001372831 
 
007239121  AAGACATTTCTTTTGTTGTTTGCACGAGCCG-----------------------------  007239151 INTRON I eCc1 
>>>>>>>>>  ||    |  | |||  |    |||| |  |                                <<<<<<<<< 
001372832  AATTGGTCACGTTTTATTAACGCACCACTCAAAAAACCACATTTCACAGTCGTGAATAAG  001372891 
 
007239152  ----------GGTAATTTTAGTTATTTCCAAGATT---------GTGGTGGAAAA-TTTG  007239191 INTRON I eCc1 
>>>>>>>>>            | | ||||| ||| | |  ||   |         ||| ||||||| ||||  <<<<<<<<< 
001372892  TCTAATTTGTGCTGATTTTGGTTTTGTTTAAAGATTAGAAACAAGTGATGGAAAAATTTG  001372951 
 
007239192  CATTGCATAAAGGTTTATTTCTATATAGCCTATCATCTTGAGTCGTTGTCGCCGCTCGTT  007239251 INTRON I eC1 
>>>>>>>>>  ||||||||||||||||||||||||||||||||||||||||  | ||  |  | ||  ||   <<<<<<<<< 
001372952  CATTGCATAAAGGTTTATTTCTATATAGCCTATCATCTTGTTTTGTCTTATCAGCCAGTC  001373011 
 
007239252  TTCTTATCAGCCAGTGAAATGTATAATCTATATGGTACTTAAATATATAGACACCACAAA  007239311 INTRON I eC1 
>>>>>>>>>  || ||                  |||||| |||  ||  || |   ||  ||       |  <<<<<<<<< 
001373012  TTTTT------------------TAATCTGTATATTATATAGA---ATTAACCGAGAGGA  001373050 
 
007239312  GTGACAGCCCAGAGGACGGACATCCCAGCCTGTCTGCCAATTGCCGGTCTAAACTGGGTC  007239371 INTRON I eC1 
>>>>>>>>>  || |||| |    ||    |||  |||  | |||||||| ||||||||  ||||||||||  <<<<<<<<< 
001373051  GTCACAGACAGACGGTGCAACACTCCAAGCCGTCTGCCATTTGCCGGTAAAAACTGGGTC  001373110 
 
007239372  TGGCCAGGGTTTACTGAATATGGTATAT-ACCCATCTACCCACTCGATTTCATGCATTTC  007239430 INTRON I eC1 
>>>>>>>>>  |  |||| | ||||   || |||||    |||  ||    || |  || |            <<<<<<<<< 
001373111  TATCCAGAGCTTACC--ATTTGGTAAGCCACCTGTCCCTGCATTGAATGTG---------  001373159 
 
007239431  GATGGGCTTATCAACACCTGAGTCACAACAACAAACAATAATTTGGGGCCTGATATTAAC  007239490 INTRON I eC1 
>>>>>>>>>   ||    |||||| ||  ||| ||| || ||  ||   |||||||||  |  |||| |||  <<<<<<<<< 
001373160  -ATATCTTTATCAGCAA-TGACTCAGAAAAAGCAA-CGTAATTTGGGTTCCAATATAAAC  001373216 
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007239491  TTAATAGCCAATGTTGTATTCTGTGTCAACAACACCACGAATTGCCAGACAATTTGCACT  007239550 INTRON I eC1 
>>>>>>>>>  || || ||   ||   ||   ||||||||||  |  ||||||| | ||||||||||||||  <<<<<<<<< 
001373217  TTTATGGC---TGGCATACATTGTGTCAACACAAAAACGAATTCCTAGACAATTTGCACT  001373273 
 
007239551  TGACTTTGTTTAATTAGGCGGTCGTT-----CGGCGTTAAATCAAATAAACGGGGTGGAC  007239605 INTRON I eC1 
>>>>>>>>>  || | |||||||||||  ||||||||      || |||||| |||| |||            <<<<<<<<< 
001373274  TGGCATTGTTTAATTAAACGGTCGTTGGTGTTGGTGTTAAAGCAAAGAAA----------  001373323 
 
007239606  TGCAGCCGAAAACCCAAAATTCTCGTAGACGTGAAGGCTTATCTGGTTGATAGAGCAGGT  007239665 INTRON I eCc1 
>>>>>>>>>      || |||||| |   | |                                | ||| |  <<<<<<<<< 
001373324  ---GGCTGAAAACGCGGTACT--------------------------------AACAGAT  001373348 
 
007239666  TCTGTTGTTTATTTCATTAATAAATTTACAGGCGAAGTACTGTGGAA-------------  007239712 INTRON I 
>>>>>>>>>  | |   | |||| |  |   | |   ||  || |||||||   ||||               <<<<<<<<< 
001373349  TATACGGGTTATCTGGTGTCTGATACTATCGGAGAAGTACCTCGGAAAGTTGGTGTTTCC  001373408 
 
007239713  -----------------------------------------------------CTGGCGA  007239719 INTRON I 
>>>>>>>>>                                                       |||| ||  <<<<<<<<< 
001373409  TATAATATATTTGTGATCCTCATTTTTTTACTTTATCAGAGGTATGAAGGTGTCTGGAGA  001373468 
 
007239720  ATTTATAATTTATAGCTGCAGAATTTTGA-------------------------------  007239748 INTRON I 
>>>>>>>>>   | ||||  | | |   |   | ||||||                                 <<<<<<<<< 
001373469  CTCTATAGATCACATACGTTTATTTTTGATCGGAAGAAGCCATACGTCTTCTAGTTTCGC  001373528 
 
Figure 14. Alignment of part intron I of D. melanogaster with the corresponding D. 
pseudoobscura ortholog. In this alignment the TF BSs found have been introduced by hand. 
CNSs retrieved with a 70% conservation filter are highlighted in light pink, HOX sites in pink, 
TIN sites in green, GATA sites in yellow. In blue writing is depicted a MEF2 site. Part of the 
shown alignment corresponds to eCIS-ANALYST cluster 1 (eCc1) observed in figure 13B. 
 
 On a final step of our analysis, we proceeded to merge the outputs of all the methods 
used. We believed that by overlapping the results we would obtain a more reliable prediction in 
order to give priority to regions to produce transgenic reporter constructs. This was not exactly 
the case. We found more discrepancies than coincidences among approaches. Figure 15 shows 
an example of the same sequence analyzed by the three methods. We consider that these 
discrepancies may be due to various reasons. For example, homology regions differ from 
program to program because “conservation” intended as sequence identity is not defined in the 
same way by the different programs. Phylogenetic comparison of  BSs present in related species 
(i.e., looking at the TF BSs in an alignment) proved to be informative due to the possibility that 
position of BSs within an enhancer might be plastic and therefore positional conservation may 
not be strictly required. The few overlapping results obtained (part of intron I, and a fragment 
6kb upstream the transcription start site containing the fragment we called “Hunch”) were given 
priority to begin in vivo cis-regulatory sequence validation. 
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D.mel  AACACCCCTTCAATTTGCTATTCAACCCCGCGCTGCTTGCACTTGACATGTTGTTGACCCAGTCTCTAGA--AAA 
                                          | |||||||||||||||||||||||||||   |||  |||   
D.pse  -----------------------------------CATGCACTTGACATGTTGTTGACCCAGTC---AGACGAAA   
 
D.mel  AGACAGACA-GACAACACAAGTCATCATCAACAAACCGCAACAAACAGAATAGAAAGTAT------CTATATCAG  
        | |||||| ||||  |  | |   || | || |||| |  |||||| |||||||||||       | || |||| 
D.pse  CGGCAGACAAGACAGGAACAATTCCCAGCCAC-AACCTCGGCAAACAAAATAGAAAGTAAGCAACCCCATCTCAG   
 
D.mel  T---TAGATACCAAA--------------------GTTCTACAGCCTTTGCTCTGTGATTTCGTGCTGAGTTCTA 
           ||||||||  |                    ||||| |||||||| |  |  |   ||||  | |  || 
D.pse  AGAATAGATACCCCATATCTCACAGAATTCCCGAGGTTCTTCAGCCTTTTCAATTAGTCATCGT-ATCATATCAT 
 
D.mel  CGATAATAAAACGAAAACAAACCG------------AAAAATTGGAATCAGCGGATTAATTTGTTTTTCAATTAG   
        ||||||  | |  | ||| |||             | |  ||  |||||      |||||||||    |  ||   
D.pse  AGATAAT--ATCCCAGACAGACCACCGCTACAGACCAGACGTTCTAATCA------TAATTTGTTGACTATATAT   
 
D.mel  TGTAGCCATTAATTGTATAATTAACGGGCAATATTTAAAGAATTTATAAGCTAAGTACATTGTGCATATAATGAG   
       | ||| |||              ||  |||  | |   |||                      
D.pse  TTTAGGCAT--------------ACTCGCACGAGTAGTAGA----------------------------------   
 
D.mel  AAAGAAAGTTAAGATACAAATCATTTTGACTCAGAATATTCCTCCTTCGCTAACAGCGACTTTTTCAGCGACTTA   
                                               |  ||||| ||                          
D.pse  ---------------------------------------CCTCCCTTCTCT------------------------   
 
D.mel  AGCACTACGACTATGTAGCGATTGCATATTTAGATAGCGGATTCTATCTATAGCTTTGAGATGTGCGTGTATGGA   
                 |||||                         ||| |||  ||  |   | | ||||||||  |||| 
D.pse  ----------CTATG-----------------------ATATTGTATGAATCTCGCCGCG-TGTGCGTG--TGGA   
 
D.mel  A----ATTGTCTATAGAACTGAAATTGCCTATGGGC-------ATAACCAACCTCCATTGTCACTTAATTGGGGG   
       |    ||||    | ||| |||| |||   |||  |       ||  ||   ||||||||||| |||||||||||    
D.pse  ACTGAATTGAAATTTGAATTGAAGTTGGAAATGTACTACTACGATTCCCGTTCTCCATTGTCATTTAATTGGGGG 
 
Figure 15. Overlapping results for part of an Ndae1 fragment 6kb upstream the 
transcription start site. VISTA output (A), eCIS-ANALYST output (B), part of the sequence 
alignment between D. melanogaster and D. pseudobscura (C), where highlighted in pink are the 
CNSs, in pale blue HOX BSs and in red TIN BSs.  
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 Homology regions, clusters of TF BSs and comparative studies of program outputs 
should be taken into account to prioritize regions for functional assays. Nevertheless, nucleotide-
to-nucleotide alignment within these regions is still required since, in an enhancer, BSs for 
different TFs might be conserved, while this might not be the case for the regions between them, 
which are subject to genetic drift rather than to positive selection. In any case, in vivo validation 
is indispensable. 
 
Expression patterns of Ndae1 transgenic reporter constructs 
Figure 16, shows the position of the sequences that were cloned in order to make transgenic 
reporter constructs for Ndae1. You can observe that we have covered the whole gene, from the 
previous CG to the next, except for 292 bp upstream the transcription start site.  
 
 
Figure 16. Ndae1 genomic and cloning map. The corresponding expression patterns are 
described in table 2 and shown in figure 17. 
 
Table 1 shows the oligonucleotides used to amplify the sequences described in figure 16. 
Table 2 summarizes the independent lines obtained for each reporter construct injection and the 
HRP expression patterns of embryos as seen for each transgenic reporter construct line. For each 
tested construct, embryos of at least two independent lines were stained both by HRP and TSA 
amplified FISH and analyzed at the confocal microscope. Figure 17  shows the expression 
patterns in embryos as seen for each Ndae1 transgenic reporter construct line described in table 
2. In the case of overlapping constructs driving the same expression pattern we show the staining 
for only one reporter construct. 
 In total, we produced transgenic flies for 12 reporter constructs (Table 2). Of these, 3 did 
not drive expression in embryos (pMC026, pMC013 and pMC020). Overlapping constructs 
showed the same expression pattern except for pMC027 and pMC013. Without taking into 
account overlapping constructs, 4 Ndae1 reporter constructs drove an expression pattern in 
embryos that corresponds to domains of expression previously described for the endogenous 
Ndae1 (Romero et al., 2000; Sciortino et al., 2001) (Table 2: pMC008, pMC27, pMC29, 
pMC038; figure 17) and one construct (pMC024; figure 17) drove an expression pattern in the 
haemocyte precursors, cells which were not described in previous in situ experiments done for 
Ndae1. 
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Figure 17. lacZ expression patterns of transgenic embryos carrying four different Ndae1 
reporter constructs. The names of the constructs are indicated to the left of the corresponding 
embryos. The patterns are described in table 2. Staining was done by HRP. The anterior part of 
the embryo is to the left and the dorsal one to the top. 
 
 We have covered the complete Ndae1 gene, from the previous CG to the next, except for 
292 bp upstream the transcription start site and we have not found the Ndae1 heart enhancer. We 
are only missing to clone and produce a transgenic reporter construct for these 292 bp upstream 
from the transcription start site. We think such short fragment is unlikely to drive expression in 
embryos in the heart. It is more likely that a bigger fragment containing these 292 bp is needed in 
order to detect a signal, as we have observed for the overlapping fragments in the 5' (see figure 
16 and table 2): although pMC029 and pMC025 drive the same expression pattern in embryos, 
pMC029, which is bigger, drives stronger expression. 
 
 
 
Bioinformatic results on the Ih channel 
We thought that comparison of the bioinformatic outputs for a set of co-expressed genes could 
raise the accuracy of prediction. Therefore, in order to analyze Ih, we undertook the same 
procedure and tools as those used to analyze Ndae1 (see above). First, the VISTA browser was 
used to depict the CNSs of Ih from whole genome pre-computed alignments among different 
species of Drosophila using D. melanogaster as base genome. As these Drosophila genomes 
show a high degree of conservation, different conservation filters were used in order to spot 
significant short conserved regions where cis-regulatory sequences might occur. Nevertheless, 
aligning the Ih sequence of D. melanogaster with the putative orthologue sequence of D. 
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pseudobscura and D. virilis we obtained the same results as for the respective analysis made on 
Ndae1: a high degree of sequence homology between the genomes of D. melanogaster and D. 
pseudobscura proved little informative as well as the scarce conservation between distant related 
species like D. melanogaster and D. virilis (Figure 18). 
 
Figure 18. Map of the Ih gene as shown in VISTA Browser. Depicted in pink are the CNSs 
between D. melanogaster as base genome and the shotgun genomic sequence of D. 
pseudobscura (second row) and D. virilis (third row) using a conservation filter of 70%. The first 
row, corresponds to the sequence alignment of the same sequence of D. melanogaster using D. 
melanogaster as base genome using AVID instead than SLAGAN as whole genome aligment 
strategy.  
 
As for Ndae1, we looked for clusters of binding sites using the rVISTA and eCIS-
ANALYST programs. Likewise, we used the same PWMs (described in “Materials and 
Methods: Bioinformatics: First bioinformatic approach based on available online tools”) and 
combinations of them as input to the programs. 
 We used rVISTA to analyze Ih, using a conservation filter of 70% and a variable window 
size (100 and 500 bp). Again, we used a “non clustering” option as a method to retrieve all 
possible BSs, even those that did not form a cluster. Figure 19 shows an example of the rVISTA 
output obtained from the comparison of the CNSs of D. melanogaster and D. virilis, defining a 
conservation filter of 70% and a window size of 100 bp (default filters of the software). Figure 
19 shows the position of TIN BSs with respect to UBX BSs in the D. melanogaster genome, the 
sites aligned between D. melanogaster and D. pseudobscura, and the sites conserved from D. 
melanogaster to D. pseudobscura. 
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Figure 19. rVISTA output for the 3’ half of Ih transcriptional unit. Shown are the 
distributions of the scored TIN and UBX BSs (top rows), the sites aligned between D. 
melanogaster and D. pseudobscura (middle rows), and the sites conserved from D. melanogaster 
to D. pseudobscura (bottom rows). Depicted in pink are the CNSs retrieved using a 70% 
conservation filter and in blue the coding sequences. 
 
 
 
5’
 
3’
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 eCIS-ANALYST was used also as a second method in the search of conserved clusters of 
TF BSs in an automatic way. We used as variables the window size and the number of TF BSs in 
a cluster. This latter variable is not an optional in rVISTA software. We also analyzed the 
distribution of TF BSs without any clustering filter. Figures 20A and 20B show how altering the 
window size varies the amount of clusters. Furthermore, note how by narrowing the window 
size, cluster 1 of figure 20A disappears in figure 20B although it appears conserved between the 
genomes of D. melanogaster and D. pseudobscura. Figure 20C instead illustrates how 
augmenting the number of TF BSs in a cluster and reducing the window size reduces the number 
of TF BS clusters, standing for a more stringent analysis. Notice that cluster 1 of figure 20A 
reappears in figure 20C.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56 
A 
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C 
 
 
Figure 20. eCIS-ANALYST output for Ih. As variable parameters, were the window size of 
1000bp (A) and of 100bp (B) and augmenting the number of TF BSs to score for within a fixed 
window of 100bp (C). 
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 Furthermore, we analyzed with our own software, the complete gene including the 
genome regions upstream and downstream until the next annotated gene. We first retrieved the 
CNSs from the whole genome alignment using VISTA tools and scored for TF BSs within these 
CNSs using PMWs. We also allowed the program to find TF BSs that slightly deviated from the 
consensus. Similarly to what we had done for Ndae1, we introduced manually in the previously 
aligned sequences all TF BSs found on the scoring step in order to distinguish aligned sites from 
conserved sites and spot regions more densely populated with the desired TF BSs. Table 3A 
shows the position and quality of the conserved and aligned TF BSs found between D. 
melanogaster and D. pseudobscura and table 3B shows the position and quality of the conserved 
and aligned TF BSs found between D. melanogaster and D. virilis. 
 
A 
 
Table 3. Summary of output for Ih using our own software. (A) Position and quality of the 
conserved and aligned TF BSs within CNSs found between D. melanogaster and D. 
pseudobscura. (B) Position and quality of the conserved and aligned TF BSs within CNSs found 
between D. melanogaster and D. virilis. 
  
 Like for the Ndae1 analysis, we found more discrepancies than coincidences by merging 
the outputs of all three softwares and no consistent information was found in order to consider 
this bioinformatic analysis as a startpoint for in vivo validation. Due to this lack of reliable 
information obtained from the bioinformatic analysis, for Ndae1 we had proceeded to clone the 
whole non-coding regions of the gene, covering in all more than 15kb. This strategy was not 
possible for Ih being the extension of the non-coding region significantly bigger than that of 
Ndae1. Therefore, we proceeded to clone only the non-coding regions of the gene with 
conserved and aligned blocks (of 1kb approximately) between the genomes of D. melanogaster 
and D. pseudobscura. Despite of the fact that sequence identity alone was not the best option, as 
stated above, it was the most reliable information we had at that moment. Taking into account 
only sequence identity among related species had been effective in identifying mammalian 
regulatory sequences (Pennacchio & Rubin, 2001) and some preliminary studies had been 
published in Drosophila (Bergman et al., 2002).  
 
 
B 
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Expression patterns of Ih transgenic lacZ reporter constructs 
Figure 21, shows the position of the sequences that were cloned in order to make transgenic 
lacZ reporter construcs. Table 1 shows the oligos used to amplify the sequences described in 
figure 21. For each tested construct, embryos of at least two independent lines were stained 
both by HRP and TSA amplified FISH and analyzed at the confocal microscope.Table 2 shows 
the independent lines obtained for each reporter construct injection and the HRP expression 
pattern on embryos as seen for each transgenic reporter construct. Figure 22 shows the 
expression patterns in embryos as seen for each transgenic reporter construct described in table 
2.  
 
 
Figure 21. Ih genomic and cloning map. The genomic map was taken from FlyBase. Depicted 
in purple are the fragments of sequences cloned independently upstream a lacZ reporter. Each 
fragment is named as “PCR” followed by a number, which is the name of the reporter construct. 
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Figure 22. lacZ expression patterns of transgenic embryos carrying four different Ih 
reporter constructs. The names of the constructs are indicated to the left of the corresponding 
embryos. The expression patterns are described in table 2. Staining was done by HRP. Anterior 
is to the left and dorsal is to the top. 
 
 
 
 
PCR1 
PCR2 
PCR3 
PCR4 
PCR5 
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The results described in this section show that the bioinformatic methods used are not 
efficient enough in finding the heart cis-regulatory region of Ih. Moreover, they show that taking 
into account only the “conservation” parameter in order to find heart cis-regulatory sequences is 
not sufficient. On the other hand, it can be argued that conservation alone is a good start point for 
a general view of regions where cis-regulatory modules for different tissues in a gene might 
occur, since, for Ih, all the transgenic reporter constructs made taking into account only 
conservation blocks between D. melanogaster and D. pseudobscura show an expression pattern 
in embryos of at least three independent lines. 
 
 
 
 A novel pattern matching based approach 
 
“Top 20” and in vivo validation 
We used a pattern matching based approach to search for motifs of known TF BSs using PMWs 
on CNSs of genes found to be overexpressed in the heart with respect to the aorta. The first 
dataset used to validate this novel bioinformatic method consisted in seven genes found by 
candidate gene approach (Ndae1, Ca-β, Ih, CaP60A, Ork1, sei and pain) and two genes obtained 
from preliminary results of microarray experiments which compared the heart transcriptome 
with that of the aorta (Dms and CG15537). This pattern matching approach consists of two 
strategies, which we named A and B. These strategies are described in detail in “Materials and 
Methods: Bioinformatics: Second bioinformatic approach based on a novel pattern matching 
based method”. We overlapped and ranked the outputs of these two strategies to produce a final 
list that we called “Top20”. For these best 20 putative Cis Regulatory Modules (CRM) we used 
Toucan to draw inside the DNA fragments each predicted binding site motif.  
Below we show the “Top 20” as ranked in the final scoring. Notice that there are 7 distinct 
genes in the top 8 and that seizure and Ca-P60 are not in this list. Each putative CRM is called 
“seq” and named according first to the gene and then with a number. Indicated in bold are 
putative CRMs assessed for in vivo validation and in table 2 is described the pattern of 
expression observed in embryos of the transgenic reporter flies. In red bold letters are the CRMs 
found to drive heart expression in embryos. Table 1 shows the oligonucleotides used to clone the 
putative CRMs to produce transgenic reporter constructs for in vivo validation. For each tested 
construct, embryos of at least two independent lines were stained both by HRP and TSA 
amplified FISH and analyzed at the confocal microscope. 
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Top 20 ranking: 
1. CG15537_seq_14 (in progress) 
2. CG15537_seq_11  
3. Ih_seq_48  
4. Dms_seq_5  
5. pain_seq_42  
6. Ndae1_seq_39  
7. Ork1_seq_9  
8. Ca-beta_seq_40  
9. Ork1_seq_25  
10. Ndae1_seq_69  
11. Ca-beta_seq_46  
12. Ca-beta_seq_55  
13. Ndae1_seq_64  
14. Ork1_seq_23  
15. CG15537_seq_1  
16. Ca-beta_seq_41  
17. pain_seq_15  
18. pain_seq_14  
19. Ih_seq_34  
20. Ndae1_seq_65  
 
 
 
Figure 23. The three heart positive CRMs with predicted TF BSs drawn with Toucan. The 
diagram shows the three positive heart CRMs with the scored TF BSs represented in colored 
boxes, drawn with Toucan. Each putative CRM is called “seq” and named according first to the 
gene and then with a number.  
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In brief, of this “Top 20” list, thirteen putative CRMs were cloned upstream of the 
minimal heat shock 43 promoter driving nGFP expression and validated in vivo. We made a total 
of nine reporter constructs (Table 2) since some of the constructs bear two putative CRMs 
(pMC050: pain-seq14+15-hs43-nGFP; pMC062: CG15537-seq1+11-hs43-nGFP; pMC067: 
Ca-beta-seq46+55-hs43-nGFP). Of these thirteen putative CRMs, one construct containing two 
predictions (CG15537-seq-1+11) drives expression in the CNS in a Hox-like regulated pattern 
(Figure 24).  
 
 
Figure 24. nGFP expression patterns of transgenic embryos carrying reporter constructs of 
Top 20 and Top 40 CRMs. The name of the reporter construct bearing the respective CRM is 
indicated below the correspondent embryo and the expression pattern is described in table 2. 
Staining was done by HRP. 
 
Three CRMs (Ork1-seq9 in pMC055; Ih-seq34 in pMC077; Dms-seq5 in pMC078) 
were found to drive nGFP expression in the heart of transgenic embryos in a pattern coinciding 
with that of the endogenous genes: exclusively in the tin-positive heart cells (Figure 25). The 
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Dms-seq5 and Ih-seq34 constructs drive expression exclusively in the heart while the construct 
containing Ork1-seq9 drives expression also in the central nervous system (Figure 24), a tissue 
known to express Ork1. For Ih-seq34 we saw only in one line staining of the gonads (Figure 24) 
and therefore we consider it a position effect of the insertion of the transgene.  
 
 
 
Figure 25. Heart positive enhancers in the Tin-positive cells. nGFP heart expression pattern 
of the three predicted CRMs as assayed by TSA amplified FISH. In green is shown the FITC 
labeled GFP probe and in red the TEXAS-RED labeled MEF2 antibody. The white arrow 
indicates one of the Tin-Positive cells where the enhancer is expressed. Pictures were taken under 
a confocal microscope using 100X magnification. Anterior is to the left. 
 
 
“Top 40” and in vivo validation 
After in vivo validation of the first dataset, we proceeded to apply the same bioinformatic 
method for cis-regulatory sequence discovery on the genes that are highly expressed in the heart 
with respect to the aorta through microarray experiments. The initial dataset consisted of 144 
genes whose CNSs were extracted and treated accordingly to strategies A and B of the 
methodology described above. The final outcome is a “Top40” ranking of putative CRMs 
(Table 4). For in vivo validation of these putative CRMs, we set further parameters as explained 
in “Materials and Methods: Second bioinformatic approach based on a novel pattern matching 
based method”. These parameters were set to reduce the number of false positives. For example, 
we gave priority to those CRMs nearest to the transcription start site of the gene or inside an 
intron of the gene). 
Table 4 shows the “Top 40” as ranked in the final scoring. As for the “Top20”, each 
putative CRM is called “seq” and named according first to the gene and then with a number. In 
bold are indicated which putative CRMs were assessed in vivo. Table 1 shows the 
heart 
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oligonucleotides used to clone the putative CRMs to produce transgenic reporter construct for in 
vivo validation. For each tested construct, embryos were stained both by HRP and TSA 
amplified FISH and analyzed at the confocal microscope. 
 
 
Table 4. “Top 40” Ranking. In bold are indicated which putative CRMs were assessed in vivo.  
 
Notice that the channel genes found by candidate gene approach are not present in the 
initial dataset. These genes are very weakly expressed and thus probably missed in the genome 
wide approach. Nevertheless, the CG15537-seq14 prediction is present both in the “Top20” and 
“Top40” lists, as well as the prediction CG15537-seq 1. Of the predicted CRMs of the “Top40” 
assayed in vivo, none of them drives heart nGFP expression in embryos, although one 
(BetaTub97-seq58+71 in pMC073) drives a Hox-like regulated pattern in the thoracic somatic 
mesoderm of transgenic embryos (Figure 24). The embryos, carrying a transgenic reporter 
construct bearing a Top40 CRM which drives an expression pattern, are shown in figure 24 and 
the correspondent expression pattern is described in table 2.  
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Genetic studies for in vivo determination of abd-A regulation of the heart 
enhancers 
The following experiments are underway. Results are expected to be collected by the end of 
April 2008. 
For the CRMs which drive expression in the heart of embryos (pMC055, pMC077 and 
pMC078), we proceeded to verify if these sequences are effectively under abd-A regulation, 
since abd-A controls heart identity and has been shown to be required for the expression in the 
heart of at least two of these genes (Ndae1 and Ih; Perrin et al., 2004; Monier et al., 2005).  For 
each construct found to drive expression in the heart of transgenic embryos, we crossed two 
independent transgenic lines to abd-A loss- or gain-of-function backgrounds. In all crosses we 
used lacZ balancers (see “Materials and Methods: Fly genetics”) in order to distinguish in the 
stained embryos those that are homozygote for the loss-of-function abd-A mutation or that carry 
the transgene allowing abd-A overexpression. 
 
Loss of abd-A function 
In order to analyze in vivo how the heart cis-regulatory sequences behave with respect to the 
function of the Hox gene abd-A, we generated flies carrying each reporter construct which drives 
expression in the heart and a complete loss-of-funtion allele of abd-A Thus, we obtained flies that 
bear the transgene which drives expression in the heart, but that lack abd-A function (see 
“Materials and Methods: Fly Genetics”). We expect the embryos of such a cross to lack the 
expression of the transgene, since we hypothesize that abd-A upregulates the expression of the 
corresponding endogenous gene.  
 
Gain of abd-A function 
To analyze if the expression of these heart cis-regulatory sequences is concomitant to the 
expression of abd-A, we generated flies that carry both the reporter construct found to drive 
expression in the heart and a UAS-abd-A transgene. We then used the UAS/GAL4 system 
described in “Materials and Methods: Fly genetics” in order to see if the ectopic expression of 
abd-A in embryos ectopically activates the nGFP reporter driven by the heart cis-regulatory 
sequences, using a late mesoderm driver (24B-Gal-4). (see “Materials and Methods: Fly 
Genetics”) 
 
Gain of Ubx function 
UBX is expressed at high concentration in the posterior aorta and in very low concentration in 
the heart portion of the cardiac tube (Ponzielli et al., 2002). In Ubx mutants, Ndae1, Ork1 and Ih 
are expressed normally. In embryos ectopically expressing Ubx in the heart, Ndae1, Ork1 and Ih 
heart expression is slightly reduced, suggesting that Ubx functions as a repressor of these genes  
(BM, LP, MS; unpublished). In order to gain insight about the role of Ubx in the regulation of 
heart specific enhancers, we analyzed the expression in embryos of these heart cis-regulatory 
sequences with respect to the ectopic expression of Ubx. We generated flies that carry both the 
reporter construct found to drive expression in the heart and a UAS-Ubx transgene. We then used 
the UAS/GAL4 system, to activate the ectopic expression of Ubx, using a late mesoderm driver 
(24B-Gal4), in order to see in embryos of this cross if the ectopic expression of Ubx lowers the 
nGFP expression in the heart driven by the heart cis-regulatory sequences (see “Materials and 
Methods: Fly Genetics”). 
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DNAseI binding assays on CRMs found to drive heart expression 
At the same time, and in order to evaluate if the predicted abd-A sites correspond to sites where 
ABD-A binds in vitro, we performed DNAseI binding assays with recombinant ABD-A protein 
on the enhancers that were found to drive nGFP expression in the heart. Figure 26 shows a map 
of the sequence of the Ork1 heart enhancer with the sites found in vitro underlined and the sites 
predicted by bioinformatics in red bold letters. Figure 27 shows with red bars, the DNAseI 
footprints made by ABD-A or UBX proteins on the Ork1 heart enhancer. Marked with a circle 
are those sites that coincide with the bioinformatic prediction. Note that not all the sites 
protected in vitro are predicted by bioinformatics. We are performing similar experiments on the 
other two heart enhancers found.  
 
 
Figure 26. Map of the sequence of the Ork1 heart enhancer. The sites found in vitro are 
underlined and the sites predicted by bioinformatics in red bold letters. 
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Figure 27. DNAseI footprints made by ABD-A or UBX proteins on the Ork1 heart 
enhancer. Marked with red bars are the footprints and with circle are those protected sites that 
coincide with the bioinformatic prediction.
1 
2 
4 
5 
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First bioinformatic analysis and in vivo validation for Ndae1 and Ih 
The bioinformatic tools used in our first in silico analysis were developed in 2004 (Grad et al., 
2004; Frazer et al., 2004; Berman et al., 2004) These tools had already been used for enhancer 
discovery in Drosophila and new enhancers had been found. For example, eCIS-ANALYST 
validation step retrieved 15 new functional enhancers out of 37 predicted enhancer sequences. 
These eCIS-ANALYST results had been obtained on early stages of Drosophila development, 
where one of the most extensively described and best understood transcriptional regulatory 
networks is acting (Berman et al., 2004). The efficiency percentage of cis-regulatory module 
discovery was reported high. On the other hand, the suite of VISTA tools (Frazer et al., 2004) 
was becoming increasingly used probably due to a user-friendly interface. In particular, the 
VISTA Browser was the only server to allow viewing pre-computed alignments of many species 
and the rVISTA tool (Loots et al., 2002), although it had been initially validated in Mammals, 
had been created on bases similar to eCIS-ANALYST and thus it allowed us to compare outputs 
among programs. This is the reason of our choice to use these tools and not others. 
Different from the validation conditions of eCIS-ANALYST, we performed our search 
on genes that are expressed late in Drosophila development. Another disadvantage with respect 
to the validation conditions of the tools used (eCIS-ANALYST and rVISTA) was that some of 
the PWMs for the TFs of interest were degenerate, such as those for HOX and GATA, or created 
de novo from very few experimentally in vitro or in vivo validated binding sites, like the SVP 
matrix. With such matrices, a higher percentage of false positives is expected a priori. For this 
matter, we performed analysis with and without a degenerate PMW and compared the results. 
We found a great deal of irreconcilable variation from the latter results and this can be due to the 
fact that the short core binding sequence (TAAT) of Hox proteins occurs very frequently in the 
Drosophila genome, leading to a higher number of false positives in our analysis. The same 
reasoning is applied when performing an analysis where the GATA PWM is introduced. 
Different from the HOX PWM, we could avoid the use of the GATA PWM in further clustering 
analysis.  
Another difficulty we encountered during in silico analysis was that of deciding which is 
the optimum window size in order to score a sequence with a given PWM. We performed 
various analyses under the same conditions and changing only the window size, in an attempt to 
define a window size when searching for heart enhancers or Hox-regulated enhancers in a 
sequence. Again, the optimum window size varied from gene to gene and depending on the 
PWMs we used to perform each analysis. No statistic criteria defined the window size and 
therefore comparison of outputs for different genes and with different matrices was the chosen 
method to determine the desirable window size. The lack of a statistic procedure to determine 
this variable increased the error of prediction, adding up to the problem of specificity of the 
PWMs.  
Moreover, depending on the window size, we also noticed a great deal of variation in the 
extension in base pairs of the clusters and in the quantity of TF BSs found within a cluster 
(Figures 13). Through the analysis of our sequences using the mentioned online tools we 
concluded that there were too many variables in order to rule out a significant number of false 
positives, and therefore we introduced all TF BSs found in an alignment. This artisan way 
allowed us to analyze where TF BSs found were, if we used different levels of stringency in the 
scoring step and how these TF BSs were positioned with respect to regions of different 
conservation percentage. This strategy allowed us to notice sites that were not found in the other 
studies because they are sites that, for example, are distant from the consensus. Since the in vivo 
tested binding sites to build the PWMs used here were few, this data could have been 
informative if we could have found a matching pattern between Ndae1 and Ih (e.g. if we could 
have found three GATA BSs for every HOX BS in one gene and in the other). Though this was 
not the case, DNAseI binding assays would have been useful to assess in vitro the information 
given by the alignment. 
To increase the efficiency of prediction, we performed a comparison analysis of the 
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outputs of the different programs used, keeping constant a small region in the gene in order to 
identify coincidences between the different tools used. Disappointing was to find only two 
overlapping results, of which were only for Ndae1. More disappointing still was to observe that 
these fragments, when tested in vivo, did not drive expression in the heart. The two overlapping 
results drove expression in the ventral nerve chord (pMC008: Ndae1-IntronI-hs43-lacZ; table 2; 
figure 17) and in the anal plate (pMC025: Ndae1-Hunch-hs43-lacZ; table 2; figure 17). 
None of the tested reporter constructs of Ndae1 drove expression in the heart. A possible 
explanation is that the Ndae1 heart enhancer is very weak and therefore maybe missed even if 
we have stained the embryos using techniques that amplify the labeling signal during a FISH 
experiment. Expression in the heart of the endogenous Ndae1 gene is very weak and hard to see 
through FISH even if the signal is amplified (BM and LP, personal communication). The 
transgenic reporter constructs we analyzed for Ndae1 cover the whole gene, from the previous 
CG to next, except for 292 bp upstream the transcription start site. Thus, there is a faint 
possibility that the heart enhancer of Ndae1 is in these 292bp. It is generally acknowledged that 
an enhancer element is around 300-1000 bp, so this could be the case. For example the cardiac 
tube enhancer of dHand is 300 bp (Han  & Olson, 2005), as the dSur cardiac tube enhancer  
(Akasaka et al., 2006; Hendren et al., 2007). Nevertheless, from the experience we have 
acquired studying Ndae1, we think it is more likely that a bigger fragment containing these 292 
bp is needed in order to detect a signal, as we have observed for the overlapping fragments in the 
5' UTR where, despite the fact that pMC029 and pMC025 drive the same expression pattern in 
embryos, pMC029 expression is stronger (data not shown). As we have recently learnt from Ih 
(see figure 22: PCRI, figure 25: Ih-seq34, table2: PCR1 “notes”), it is possible that by adding 
these few bases to the construct pMC029 (see figure 16) we retrieve heart specificity. It is worth 
noticing, though, that this short Ndae1 fragment has not been detected in the different outputs of 
our in silico analysis. 
Evaluating our results altogether, a second possibility raised is that elements that are 
distant from each other need to interact in order to activate transcription, and this is a situation 
that we could not have detected either through bioinformatics or molecular methods. The next 
question then would be: which are the fragments that interact? 
The transgenic reporter lines for Ndae1 constructs that drove an expression pattern 
(Figures 17) did so in domains of expression of the gene already described by in situ 
hybridization (Romero et al., 2000), except for the lines Ndae1-InVII-hs43-lacZ (pMC024, see 
Table 2 and Figure 17) which are expressed in the haemocytes, an expression domain not yet 
been described for Ndae1. Furthermore, it is probable that the lateral cells stained in the embryos 
bearing the construct Ndae1-InIII-hs43-nGFP (pMC035; Table 2 and Figure 17) are cells of the 
peripheral nervous system (PNS), but a double staining with anti-GFP and an antibody  for a 
general marker of  the PNS, like 22C10 (Kania et al., 1995), is required for confirmation. 
Nevertheless, and although we made transgenic constructs covering the whole gene, we did not 
find the enhancer regions for all of the organs/tissues where Ndae1 is reported to be expressed. 
For example, we have not found the enhancer of Ndae1 that drives expression in the Malpighian 
tubules (MT) nor the one that drives expression in the central nervous system.  Again, like in the 
case of the heart, this raises the possibility that Ndae1 expression in the MT and CNS is driven 
by elements that are distant from each other and need to interact in order to activate transcription. 
Therefore only by assessing bigger reporter constructs or combining fragments in a reporter 
construct we will be able to identify them. Furthermore, is not to disregard again the possibility 
that the not-cloned 292bp may contain one or both these enhancers. Again, immunoprecipitation 
of the whole Ndae1 genomic DNA would be necessary to provide us with some hints for a start 
point. 
In addition, the expression patterns observed are not reported domains of expression of 
the combination of two or more of the TFs used in this in silico analysis. On the contrary, the 
choice of the TFs used was made on the assumption that the unique combination of all of them 
confers heart specificity to any given target gene. For example, abd-A confers heart specificity 
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(Ponzielli et al., 2002) and tin is expressed exclusively in the mesoderm and becomes restricted 
to the cardiac cells later in embryogenesis (Bodmer, 1993). One could expect that a cluster 
containing TIN BSs and ABD-A BSs drives expression in the heart. Nevertheless, we have 
observed that the fragment where we obtain overlapping results among the bioinformatic 
approaches (see Figure 15), although it contains TIN and ABD-A BSs, drives expression in the 
anal pads, an expression domain not described for either tin or abd-A. This gave us a clear 
example of a false positive bioinformatic output. 
As we already referred, the clustering methods were setting a benchmark in 2004. 
Nevertheless, the validation of these methods had been done either in early stages of 
development of Drosophila (eCIS-ANALYST), where the transcriptional regulatory network 
governing these stages was well known and characterized, or in humans (rVISTA). In spite of all 
this, the accuracy of prediction of these methods had not been tested in poorly characterized 
genes in later developmental stages of Drosophila. For this reason, and because of the 
ambiguous bioinformatic results we had obtained for Ih and Ndae1 using clustering methods, for 
Ih we decided to contemplate only the sequence identity variable as a starting point to clone and 
produce transgenic reporter flies to test in vivo the bioinformatics predictions. Most methods 
reported up to 2004 used interspecies sequence comparison alone as a method to identify 
regulatory sequences. These methods had been remarkably effective in identifying mammalian 
regulatory sequences (Pennacchio & Rubin, 2001) and some preliminar studies had been 
published in Drosophila (Bergman et al., 2002). 
For Ih, all the transgenic flies show expression in embryos in tissues that we are not 
certain they belong to the endogenous gene expression pattern (see table 2 and figure 22), since 
until now there are no data describing it. The in situ hybridization experiments we have 
performed to describe the pattern of expression of the endogenous gene have been done by 
FISH, and we have obtained high background. For this matter, we are performing ISH with 
alkaline phosphatase in order to determine if the found enhancer elements actually belong to Ih. 
Nevertheless, none of these constructs was expressed in the heart. Ih expression in the heart is 
slightly stronger than that of Ndae1, therefore less likely to be missed by the observer when 
analyzing embryos stained by amplified FISH. This raised again the possibility that distant 
elements might be interacting to activate transcription. Another plausible explanation was that 
the sequences we had cloned to make the reporter constructs were too short, and therefore 
missing the piece that confers heart specificity to the enhancer. In fact, just recently, we found 
out this to be the case (see figure 22: PCR1 and figure 25: Ih-seq34-hs43-nGFP, table 2: 
PCR1 “notes”). 
The results obtained show that this first bioinformatic analysis we applied is not efficient 
in finding heart cis-regulatory regions. Moreover, we showed that taking into account only the 
“conservation” parameter in order to find heart cis-regulatory sequences is not sufficient, at least 
in Drosophila. On the other hand, it can be argued that conservation alone is a good start point 
for a general view of regions where cis-regulatory modules for different tissues where a gene 
might be expressed, since all the transgenic reporter constructs made for Ih were made taking 
into account only conservation blocks between D. melanogaster and D. pseudobscura and they 
all show an expression pattern in embryos in at least three independent lines. Still, we think that 
searching for conserved clusters of BSs for all the TFs known to be involved in heart 
development was the method to use if we needed to assay a large number of genes. 
Subsequently, with the data obtained from microarray experiments we found the urge to refine 
our bioinformatic approach, since assessing through transgenic constructs the whole sequence 
for each putative abd-A-regulated heart specific gene would have been an unaffordable 
enterprise. 
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The pattern matching based approach and in vivo validation of heart specific 
enhancers 
Through the three years of this project, seven genes were found to be differentially expressed 
along the cardiac tube through a candidate a gene approach. Moreover, the data obtained from 
microarray experiments showed 144 genes overexpressed in the heart with respect to the aorta. 
This rendered the pool of putative abd-A target genes so large that could only be assessed 
through bioinformatic approaches. Since there were no bioinfomatic tools available for Hox 
specific targets, we designed our own method combining clustering strategies that gave priority to 
high affinity ABD-A BSs on one hand and to the conservation of heart expressed TF BSs on the 
other. This new method was first tried using as initial dataset seven genes found by candidate 
gene approach plus two genes found through microarray experiments. This analysis lead to the 
list of 20 best predictions, the “Top20”. Using this small initial dataset we have found three 
heart enhancers for three different genes. The rank position of these three positive CRMs (fifth, 
ninth and nineteenth) in our “Top20” list lead us to think the method can be used to find Hox 
target enhancers. Taking into account only the validated in vivo CRMs, it results that the 
efficiency of prediction is high (3/13 = 23%). Moreover, when applying the same method to a 
large initial dataset constituted by the 144 genes found through microarrays, with an outcome of 
a “Top40” list, we found that the predictions in the “Top20” for the gene CG15537 (CG15537-
seq14 and CG15537-seq11) can be retrieved again in the “Top40”. On the other hand, it is to 
notice, that the CRM found in the “Top20” for the gene Dms, which is a true positive 
prediction, cannot be found in the “Top40”. We did not obtain significant scores for the 
predictions of the genes seizure and Ca-P60, which can indicate that the parameters used are 
stringent enough to exclude false positives.  
For the “Top40” ranking we have not found yet any positive result in the in vivo 
validation, but it is also true that we have not yet in vivo validated enough predictions in order to 
arrive to any conclusion. Nevertheless, so far, we have found one Hox-like regulated enhancer 
(BetaTub97-seq58+71 in pMC073) out of nine. The construct made with CG10440-seq80+89 
(pMC069, table 2), bearing two predictions ranked positons 1 and 7, respectively, in the 
“Top40” did not drive expression in the heart. CG10440 encodes a voltage gated potassium 
channel protein. CG10440 has been detected to have a 2.5 fold change expression in the genome 
wide approach (data not shown) while the other mentioned channel proteins have not been 
detected in the microarray output. As we have noticed before, channel proteins have a very weak 
expression in the heart and thus are difficult to detect. In fact, the endogenous expression of these 
channels may be detected only using the FISH technique with an amplification step by means of 
TSA and using confocal microscopy. Consequently, the heart enhancers of these channels are 
difficult to identify. It is possible that the heart enhancer of this channel protein lies within the 
prediction but we have not detected it due to technical problems. Thus, we are producing a 
construct that bears the putative CRM CG10440-seq80 within a bigger piece of genomic DNA, 
since it is acknowledged that this strategy usually increases the signal of the reporter and we have 
seen this to be the case for overlapping constructs of Ndae1.  
In any case, more predicted CRMs of this “Top40” need still to be analyzed. The next 
sequences that will be validated in vivo, will be first validated in vitro. Since validation in vivo is 
time consuming, we will perform inmunoprecipitation assays using ABD-A protein, in order to 
validate more predictions in a shorter time. Those CRMs, which are positive also in in vitro 
assays, will be cloned upstream of the nGFP reporter and injected to produce transgenic flies and 
examine expression in embryos. 
In a second bioinformatic step, we decided to perform a search using the positive results 
as model targets. We first compared, the enhancers among them and after with the other genes of 
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the dataset. We have not found similarities among the sequence position of the motifs in the 
enhancers. Moreover, when comparing these positive results to the genes in the dataset, we have 
not found similarities. This is leading us to think that there is no repetitive pattern of TF BSs. In 
other words, that there might be no trace in the DNA sequence in order to predict a prototype 
heart enhancer. From another point of view, we are comparing the positive results with the 
orthologous sequences of species other than D. pseudobscura. In this analysis the method used 
is described in Aerts et al., 2007. Finally looking at the initial dataset one can observe that genes 
belonging to different Gene Ontology (GO) groups have been analyzed in the same way. Instead, 
one can think, that, for example, Ih, encoding a channel protein, has a different structure of its 
heart enhancer than Dms, which encodes a peptide hormone, but probably similar to that of 
Ork1, which also encodes a channel protein. Supposing that different GO groups have different 
heart enhancers, we are designing new filters to apply to the cis-regulatory search in order to take 
into account the function of the target gene. 
 In vitro and in vivo data will also provide evidence about the trace TFs may leave in the 
sequence they regulate. Indeed, from the DNAseI footprints on the Ork1 heart enhancer, it is 
curious to notice that there are sites like “site 1” (put sequence, figure 26) that are not typical 
ABD-A or UBX binding sites, as it does not have a TAAT or TAAT-like core. We have shown 
also that not all the binding sites protected in vitro are predicted by bioinformatics (figure 27), 
at least for the Ork1 heart enhancer. To understand which are the in vivo functional BSs of 
ABD-A, mutagenesis experiments are being performed in the following way: 
 
mutate all the ABD-A biding sites found through DNAseI assays; 
mutate only the ABD-A binding sites found through bioinformatics. 
 
The mutated enhancers have been cloned upstream of nGFP and will be injected in fly 
embryos in order to produce mutated reporter construct flies. Again we will assay the expression 
of these constructs in embryos and perform fly crosses in order to assay expression in a 
background where abd-A is overexpressed. This in vivo data will provide the necessary evidence 
to find out not only which of such ABD-A BSs are functional in vivo, but also will determine 
whether these heart enhancers are direct targets of the Hox gene abd-A. Moreover, if these 
“unconventional” BSs found by footprints were to be functional, then we could start studying if 
such sites are present in all heart enhancers under abd-A control to analyze the possibility these 
“unconventional” BSs are the reason of heart specificity.  
 Analyzing the expression of the heart enhancers in abd-A gain and loss of function 
backgrounds will provide strong evidence about the key role of abd-A in granting heart specificity 
to these genes. Although abd-A confers heart specificity, probably it does not account on its own 
for specific target gene expression, because the target genes we have found (and thus their 
enhancers) are expressed only in the four TIN-positive cells of each segment that constitutes the 
heart. In order to evaluate if there is cooperation of ABD-A and TIN for the regulation of such 
target genes, we are also performing DNAseI binding assays on the heart enhancer sequences 
using TIN protein, and we have in program to perform protein-protein interaction studies.  
Nevertheless, we do not exclude other TFs, like TBX or HAND participating in the regulation of 
the expression of the heart specific genes found.  
 Though UBX is found at very low concentrations in the heart cells of the cardiac tube, we 
have not excluded a possible role of UBX as a repressor in the regulation of these heart 
enhancers. To gain insight in this matter we will study reporter gene expression in a Ubx gain-of-
function background. If the expression of the transgene remains unaltered we could conclude Ubx 
is not involved in regulation of genes expressed differentially in the heart with respect to the 
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aorta. Instead, if expression of the reporter is not observed or is lowered, we will provide 
evidence for a possible repressor role of UBX in the regulation of heart specific genes.  
 From a broader point of view, we are analyzing the late role of abd-A as an activator. 
There is only indirect evidence that ABD-A is an activator and UBX is a repressor in late stages 
of cardiogenesis (BM, LP, and MS, unpublished). This has remained an open question due to the 
impossibility of assaying expression in double mutant flies, because such flies do not have 
appropriate abdominal lineage choice, which is the early function of Ubx and abd-A in 
cardiogenesis (Perrin et al., 2004). Thus, in these double mutant embryos, all cardiomyocytes are 
specified as thoracic cardiomyocytes.  To learn more about this situation, we have crossed flies 
deficient for abd-A and Ubx (Df 109 flies; see “Materials and Methods: Fly Genetics”) to flies 
which bear the UAS>abd-AHx transgene (Merabet et al., 2003). UAS>abd-AHx. are flies which 
carry an inducible mutated hexapeptide variant of abd-A capable of maintaining normal lineage 
choice in early cardiogenesis and also capable of repressing Ubx, but unable to lead to ectopic 
expression of, for example, the target gene Ih (BM, LP and MS, unpublished). Thus, the absence 
of Ubx does not seem to allow expression of Ih, which may require positive regulation by abd-A. 
Recombinant UAS>abd-AHx, Df109 flies where then crossed to recombinant 24BGal4, Df109 
flies (see “Materials and Methods: Fly Genetics”). One fourth of the progeny of this cross will 
be homozygous for the Df109 chromosome (lack Ubx and abd-A) and will express abd-AHx in the 
whole mesoderm (due to the 24BGal4 driver). By eliminating both Hox genes, but leaving intact 
normal lineage choice towards abdominal fate so that the cells that form the heart and posterior 
aorta become specified, we will analyze how does differentiation of cardioblasts proceed in the 
absence of late Hox input. 
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Conclusions 
We use cardiogenesis in Drosophila as a model to study Hox function in organogenesis and Hox 
specificity during development. The aim of this work was that of gaining knowledge on the role 
of   abd-A in conferring heart identity. For this we needed to find the heart enhancers of putative 
direct Hox target genes expressed only in the heart portion of the cardiac tube and evaluate if 
abd-A genetically regulates these enhancers and if abd-A protein binds to this enhancer 
sequences. In the process of this project we have learnt that the specific heart cis-regulatory 
sequences of putative abd-A heart targets are difficult to assess in vivo since we have found out 
that these can only be detected by the use of FISH techniques using TSA amplification and 
confocal imaging. Nevertheless, we have found three heart enhancers that belong to three true 
realizator genes and which we are in the process of analyzing in order to determine if these are 
direct abd-A targets and if they are co-regulated also by other TFs, such as TIN.  
From another point of view, we have designed a bioinformatic method to detect heart 
enhancers of abd-A target genes in order to speed up the in vivo search of heart enhancers. Hox 
genes are difficult to assess through bioinfomatics or in vitro since their proteins bind to a short 
TAAT core sequence which occurs every 1 kb in the genome and that produces a PWM said to 
be highly “degenerate”. Nevertheless, our method has detected three heart enhancers and two 
Hox-like regulated enhancers, and although this method still needs optimization, the efficiency of 
enhancer discovery has proven to be high. Finding other heart enhancers and adding filters like 
grouping by GO will help in the optimization. The ultimate aim of this work in progress is to 
arrive to construct a prototype heart enhancer that will help us understand abnormalities which 
can lead to congenital heart diseases. What we have learnt up to the moment from the three heart 
enhancers found is that they do not have characteristics in common such as the quality, quantity 
or position of TF BSs. Therefore, we need to determine which are the functional sites in vivo to 
arrive to any conclusion. From an evolutionary point of view, since the larval heart of 
Drosophila is an organ dispensable for viability, it is possible that the turn over rate of heart TF 
BSs is high and therefore heart enhancers are not highly conserved. Interspecies studies will 
throw light into this matter. Despite many efforts, we are still far from understanding how Hox 
genes, like abd-A, regulate downstream realizators in order to form a functional organ like the 
heart.  
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Table 1: Oligonucleotides 
NAME SEQUENCE USE CONSTRUCT 
oLP 001 Ih 5primeF CGAATCGGTGTGTTTCTGC clone Ih PCR1 in CHAB Ih PCR1 lacZ 
oLP 002 Ih 5primeR CCATCGAACACGGTACTCAT clone Ih PCR1 in CHAB Ih PCR1 lacZ 
oLP 003 Ih IntronIF GAATCGAACGCGTTAACCG clone Ih PCR2 in CHAB  Ih PCR2 lacZ 
oLP 004 Ih IntronIR GCCTTTAGTTGGTGCCTTCA clone Ih PCR2 in CHAB  Ih PCR2 lacZ 
oLP 005 Ih IntronVIF TTCTCAAACCATCTGACGC clone Ih PCR3 in CHAB Ih PCR3 lacZ 
oLP 006 Ih IntronVIR CCCCACTTCTCTTGTTTTGTA clone Ih PCR3 in CHAB Ih PCR3 lacZ 
oLP 007 Ih IntronVI 
3primeF AGCTTCTTGGAGTGACACC clone Ih PCR4 in CHAB Ih PCR4 lacZ 
oLP 008 Ih IntronVI 
3primeR GCCACCAAAAACACACACAC clone Ih PCR4 in CHAB Ih PCR4 lacZ 
oLP 009 Ih 3primeF AAAAGGAACCCCAAGACGC clone Ih PCR5 in CHAB Ih PCR5 lacZ 
oLP 010 Ih 3primeR CGGTCCAGTTTGGAGACTTA clone Ih PCR5 in CHAB Ih PCR5 lacZ 
oMC007 ndaeIF Not GGCGGCCGCCTGAAAAGAAGAGTGGCATT clone Ndae intron I in CHAB pMC008: Ndae1-inI-lacZ 
oMC008 ndaeIR Bam GGGGATCCGTAAGTAGGACGGTGTGATT clone Ndae intron I in CHAB pMC008: Ndae1-inI-lacZ 
oMC013 GGATCCGGTGTGCTAATCAAGTTTACGTCG to clone "the hunch" of Ndae in CHAB 
pMC025: Ndae1-Hunch-
lacZ 
oMC014 CCGCGGACAACAGGGCGTATGAATTCG to clone "the hunch" of Ndae in CHAB 
pMC025: Ndae1-Hunch-
lacZ 
oMC015#2 
5'UTR4.4NdaeF 
CGGGATCCGCCGATCTTTAAACTGAAGCA to clone 3' of 5' UTR of 
Ndae in CHAB (fra4.4) 
pMC029: Ndae 
5’UTR4.4-lacZ 
oMC016#2 
5'UTR4.4NdaeR 
ATCCGCGGGACAACAGGGCGTATGAATTC to clone 3' of 5' UTR of 
Ndae in CHAB (fra4.4) 
pMC029: Ndae 
5’UTR4.4-lacZ 
oMC017#2 
5'UTR4.6NdaeF 
CGGGATCCCAACCCAACACCCCTTCA to clone middle of Ndae 
5' UTR in CHAB (fra4.6) 
pMC027:Ndae 5’UTR4.6-
lacZ 
oMC031 3'UTRNdaeF CCGCTCGAGCTTCAATATAAAATGGCATATTTGCA to clone 3'UTR of Ndae in CHAB pMC020: Ndae1-3’-lacZ 
oMC032 3'UTRNdaeR CGGAATTCAAAATCCCACGGACCAGTG to clone 3'UTR of Ndae in CHAB pMC020: Ndae1-3’-lacZ 
oMC033 InVIINdaeF TTGCTCGAGCTGTAATATAAACCATTGGGTACAGTT to clone intron VII of Ndae in CHAB 
pMC024: Ndae1-inVII-
lacZ 
oMC034 InVIINdaeR CCGGAATTCGTGAGTCGAATAAATCAATTAAAACAA to clone intron VII of Ndae in CHAB 
pMC024: Ndae1-inVII-
lacZ 
oMC035 InIIINdaeF CCGCTCGAGCTGCATTAGTCGCGTTTTTTT to clone intron III of Ndae in CHAB pMC028: Ndae inIII-lacZ 
oMC036 InIIINdaeR TTTTTGCGGCCGCGTGAGTATGGGGGTGTTCAC to clone intron III of Ndae in CHAB pMC028: Ndae inIII-lacZ 
oMC037 InIINdaeF GGCTCGAGGTTCAAGGATACTTTATGAGAAACAGA to clone intron II of Ndae in CHAB pMC026: Ndae-inII-lacZ 
oMC038 InIINdaeR GGCTCGAGGTTCAAGGATACTTTATGAGAAACAGA to clone intron II of Ndae in CHAB pMC026: Ndae-inII-lacZ 
oMC049 
Ndae5'UTR4.6Not-F 
AAAGCGGCCGCCCCAAAGTGGACATGCAG to clone middle of Ndae 
5' UTR in CHAB (fra4.6) 
pMC027:Ndae 5’UTR4.6-
lacZ 
oMC055 Ndae-inV-VI-F CCGGATCCCTGAGGATTTCAAAAAGCAAAAGT to clone inV+VI in Chab NOT injected 
oMC056 Ndae-inV-VI-R GGGAATTCGTAAGGAATCTTTTTAGGCTTTAAAGA to clone inV+VI in Chab NOT injected 
oMC057 Ndae-inIII-5'-
chopF 
CCGCTAGCCTGCATTAGTCGCGTTTTTTT to clone 3' of intron III in 
pH-Stinger 
pMC035: Ndae-InIII 
nGFP + pMC036: Ndae 
InIII 3’half-hs43-nGFP 
oMC058 Ndae-inIII-5'-
chopR 
CCAGATCTAATCTAGTATGCCTTTTACTCTACGAA to clone 3' of intron III in 
pH-Stinger 
pMC036: Ndae InIII 
3’half-hs43-nGFP 
oMC060 Ndae-inIII-3'-
chopR 
CCAGATCTTGAGTATGGGGGTGTTCAC to clone 5' of intron III in 
pH-Stinger 
pMC035: Ndae-InIII 
nGFP 
oMC72 Ih5'TST-F   CCTCTAGAAAGGGGTCATCCGTCACTCCAGT to clone bigger Ih PCR1 pMC040: BS Ih PCR6 
oMC073 Ih5'TST-R CCTCTAGACAATGAGTACCGTGTTCGATGGC to clone bigger Ih PCR1 pMC040: BS Ih PCR6 
oMC78 NdaeInIII+eIII-
VII-F 
GGTCTAGACTGGCGCAGGAACATATAGTCTGG to clone inIII + 
environment 
pMC038: Ndae 
inIII+environment-hs43-
nGFP 
oMC79 NdaeInIII+eIII-
VII-R 
GGTCTAGAGCACAGCGAGTTCAATTCATACTTG to clone inIII + 
environment in pHStinger 
pMC038: Ndae 
inIII+environment-hs43-
nGFP 
oMC104 Dms5'-1011-
S/E 
CCGAATTCCTATCTTCTCACTGCATTAGTCAC 
to clone Dms CNS 1+2 in 
pStinger (and pH-
Stinger?) 
pMC046: Dms-seq5-
nGFP + pMC078: Dms-
seq5-hs43-nGFP 
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NAME SEQUENCE USE CONSTRUCT 
oMC110 15537-seq14-
F/E 
CCGAATTCGCATGTCGCAGGTTCCAATAAATG to clone CG15537 seq14 
in pStinger 
pMC049: CG15537-
seq14-nGFP + pMC077: 
CG15537-seq14-hs43-
nGFP 
oMC111 15537-seq14-
R/B 
CCGGATCCGCAATCTGAGGAAGGGGTAAAAGC to clone CG15537 seq14 
in pStinger 
pMC049: CG15537-
seq14-nGFP + pMC077: 
CG15537-seq14-hs43-
nGFP 
oMC114 Pain-seq42-F/E CGGAATTCGACCTTTTAAGTACGGATGCCAC to clone pain seq42 in pH-Stinger 
pMC052: pain-seq42-
hs43-nGFP 
oMC115 Pain-seq42-R/B GGGGATCCGGGAGATGAGTTCAAATTGGGAC to clone pain seq42 in pH-Stinger 
pMC052: pain-seq42-
hs43-nGFP 
oMC116 Pain-seq14+15-
F/E 
CCGAATTCGTAAACAAACCCGTCAATCAACC to clone pain seq14+15 in 
pH-Stinger 
pMC050: pain-seq14+15-
hs43-nGFP 
oMC117 Pain-seq14+15-
R/B 
CGGATCCCTGCACATCACAAAAGTGGATAAT to clone pain seq14+15 in 
pH-Stinger 
pMC050: pain-seq14+15-
hs43-nGFP 
oMC118 Ih-seq34-F/E GGGAATTCGCGCCGGTGTTTAGCTATATCAAC to clone Ih seq34 in pH-Stinger 
pMC051: Ih-seq34-nGFP 
+ pMC066: Ih-seq34-
hs43-nGFP 
oMC119 Ih-seq34-R/B GGGGATCCTGGAGGGAGACGAAACGCAG to clone Ih seq34 in pH-Stinger 
pMC051: Ih-seq34-nGFP 
+ pMC066: Ih-seq34-
hs43-nGFP 
oMC122 
BetaTub97seq58-F/K 
AAGGTACCAGAGGAGGCGCACTAAACACTAAAT 
to clone BetaTub97 
seq58 in pHStinger 
(1688bp) 
pMC065: betaTub97-
seq58-hs43-nGFP 
oMC123 
BetaTub97seq58-R/B 
ATGGATCCGGTTGGGGTGAGAGAGGACTAATTT 
to clone BetaTub97 
seq58 in pHStinger 
(1688bp) 
pMC065: betaTub97-
seq58-hs43-nGFP 
oMC0124 
BetaTub97seq71-F/Bg 
TTAGATCTTTCATTGTCGTGTAATTTGTGCAG 
to clone BetaTub97 
seq71 in pHStinger 
(1351bp) 
pMC072: betaTub97-
seq71-hs43-nGFP 
oMC0125 
BetaTub97seq71-R/Xb 
CCTCTAGAACGGAGTGAGCAGATAATTTTGCTT 
to clone BetaTub97 
seq71 in pHStinger 
(1351bp) 
pMC072: betaTub97-
seq71-hs43-nGFP 
oMC0126 
CG10440seq80-F/K 
AAGGTACCGTGCAGGTGTGACTGTGTGTGTG to clone CG10440 seq80 
in pHStinger (1068bp) 
pMC061: CG10440-
seq80-hs43-nGFP 
oMC0127 
CG10440seq80-R/B 
ATGGATCCTCCGAATGGCTGCTACGAATAGTAA to clone CG10440 seq80 
in pHStinger (1068bp) 
pMC061: CG10440-
seq80-hs43-nGFP 
oMC0128 
CG10440seq89-F/Bg 
CCAGATCTGTATTTAAACTGCATCGACTTTTGA to clone CG10440 seq89 
in pHStinger (1322bp) 
pMC068: CG10440-
seq89-hs43-nGFP 
oMC0129 
CG10440seq89-R/Xb 
TGTCTAGATTACAAATTAGCCGTCAATGGAG to clone CG10440 seq89 
in pHStinger (1322bp) 
pMC068: CG10440-
seq89-hs43-nGFP 
oMC130 Trim-seq129-
F/K 
TGGGTACCGATGGATGTGTTTTCATAGCAACCT to clone Trim seq129 in 
pHStinger (1079bp) 
pMC064: Trim-seq129-
hs43-nGFP 
oMC131 Trim-seq129-
R/B 
TTGGATCCTGTGCTACGTGTGCGACATTTTC to clone Trim seq129 in 
pHStinger (1079bp) 
pMC064: Trim-seq129-
hs43-nGFP 
oMC132 Trim-seq138-
F/Sp 
TAGCATGCCAGACGAGTTGTTACCGGTATTGGT to clone Trim seq138 in 
pHStinger (1611bp) 
pMC070: Trim9-seq138-
hs43-nGFP 
oMC133 Trim-seq138-
R/Xb 
ACTCTAGAGGCTTTTAGCAATTTAACGCACAG to clone Trim seq138 in 
pHStinger (1611bp) 
pMC070: Trim9-seq138-
hs43-nGFP 
oMC134 
CG15537seq1+11-F/K  
GGGGTACCGTCATTCTCTGCGTCTTAATTTGC 
to clone CG15537 
seq1+11  in pHStinger 
(3448bp) 
pMC062: CG15537-
seq1+11-hs43-nGFP 
oMC135 
CG15537seq1+11-R/B  
GGGGATCCGGATTGTCATGCTCTTGTCATCTC 
to clone CG15537 
seq1+11  in pHStinger 
(3448bp) 
pMC062: CG15537-
seq1+11-hs43-nGFP 
oMC136 Ork-seq9-F/Sp CCGCATGCCAGATTGATTGATGTCTAGAGAACC to clone Ork1 seq9 in pHStinger (1053bp) 
pMC055: Ork-seq9-hs43-
nGFP 
oMC137 Ork-seq9-R/SII GTCCGCGGTTCGCAAAGACTTGTCGCAAATATA to clone Ork1 seq9 in pHStinger (1053bp) 
pMC055: Ork-seq9-hs43-
nGFP 
oMC140 Cabeta-seq55-
F/Sp 
AAGCATGCGTCTTGTCGCTAATTTCATAGGAGT to clone Cabeta seq55 in 
pHStinger (1132bp) 
pMC063: CaBeta-seq55-
hs43-nGFP 
oMC141 Cabeta-seq55-
R/Sg 
CTCGCCGGCGAAGACGTGGTTCTATAATTCAATTTG to clone Cabeta seq55 in 
pHStinger (1132bp) 
pMC063: CaBeta-seq55-
hs43-nGFP 
oMC142 Cabeta-seq46-
F/Nh 
TCGCTAGCGCACTAAAGGTTCTTGAAAAGCTGC to clone Cabeta seq46 in 
pHStinger (1253bp) 
pMC059: CaBeta-seq46-
hs43-nGFP 
oMC143 Cabeta-seq46-
R/B 
CCGGATCCCGTGGCATTTTATGTGTCATCAAC to clone Cabeta seq46 in 
pHStinger (1253bp) 
pMC059: CaBeta-seq46-
hs43-nGFP 
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Table 2: Reporter Constructs and Expression Patterns 
FIG CONSTRUCT ALL LINES EMBRYOS HRP 
EMBRYOS 
FISH NOTES 
 22 Ih PCR1-hs43-lacZ 1, 2, 3, 4, 5, 6 amnioserosa amnioserosa beside seq34 
22  Ih PCR2-hs43-lacZ 7, 8, 9, 10 lymph glands?     
22  Ih PCR3-hs43-lacZ 11, 12, 13, 14 rectum     
22  Ih PCR4-hs43-lacZ 15, 16, 17 brain?     
22  Ih PCR5-hs43-lacZ 18, 19, 20, 21 ALL: amnioserosa amnioserosa 
includes 
seq48 
17  pMC008: Ndae1-inI-hs43-lacZ F11y,  F15red,  F16or, M8red, F16dk or 
CNS only in 
MIX     
 NS pMC013: Ndae1-5’XB-hs43-lacZ F11dk or, F11red, F32or, F32red nothing   
most 5' 
fragment 
of 
Ndae1 
NS pMC020: Ndae1-3’-hs43-lacZ F20, F20jumps #48 #51 #57 nothing     
17 pMC024: Ndae1-inVII-hs43-lacZ M2, M3, M4, F5 haemocytes haemocytes   
17 pMC025: Ndae1-Hunch-hs43-lacZ M1, M3, M6, M8 anals pads     
NS pMC026: Ndae-inII-hs43-lacZ F1, M6, M7, M8   nothing     
See 
pMC
025 
pMC027: Ndae 5’UTR4.6-hs43-lacZ F2, F2jumps: #10red  #13 #20dkor    
weak anal 
pads in late 
embryos 
    
17 pMC028: Ndae inIII-hs43-lacZ F4, F11, M1, M9 
amnioserosa+ 
lateral cells 
(PNS?) 
    
See 
pMC
025 
pMC029: Ndae 5’UTR4.4-hs43-lacZ F3, M3, M8, M12  anal plate     
See 
pMC
028 
pMC035: Ndae-InIII-hs43-nGFP F4, F14, F55, F57, M8, M20, M30 
amnioserosa+ 
lateral cells 
(PNS?) 
    
See 
pMC
028 
pMC036: Ndae InIII 3’half-hs43-nGFP F2, F4, F9, F17, F30, M7, M22 
amnioserosa+ 
lateral cells 
(PNS?) 
(stronger than 
035 and 038) 
    
See 
pMC
028 
pMC038: Ndae inIII+env-hs43-nGFP F3, F9, F16, F31, F49, F52, F58, F61, M6, M21 
lateral cells 
(PNS?)     
NS pMC046: Dms-seq5-nGFP                                                 M1, F2, F3, F4                                          nothing   
with 
hs43 P: 
heart 
NS pMC049: CG15537-seq14-nGFP                                                                                               F10, M1, M2, M3, M4, M8                            nothing   
with 
hs43 P: 
heart 
24 pMC050: pain-seq14+15-hs43-nGFP F10, M1, M2, M4, M5, M7, M8, M9 
M1: head, 
salivary glands 
from stg 10, 
sMD           
M5: as 1M but 
weaker 
M9, M4                                                               
  24 pMC051: Ih-seq34-nGFP                                                       M2m1, F6, F5  M2m1, F6, F5: nothing     
24 pMC052: pain-seq42-hs43-nGFP M1, M2, M3, M4, F5, M6  
M6: head, 
oesophagus, 
VM 
longitudinal, 
midline         
F5 M2: 
stronger than 
M6 + CNS 
M2, M4   
 24 
& 
25 
pMC055: Ork-seq9-hs43-nGFP F25, F7, M9or m, M11  
F25, F7, 
M9orm, M11: 
CNS 
M9orm, 
M11: CNS 
heart 
  
24 pMC062: CG15537-seq1+11-hs43-nGFP F22y, F22r, M3, M5,  M27, M30 
F22y, F22r, 
M3, M27, 
M30: CNS 
endoderm VM 
lateral staining  
M30, F22: 
CNS 
endoderm 
VM lateral 
staining  
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FIG CONSTRUCT ALL LINES EMBRYOS HRP 
EMBRYOS 
FISH NOTES 
24 pMC066: Ih-seq34-hs43-nGFP 
F1y                                                                      
F1y jumps: #1 #6 #13  
#15  #28 #30  #36  #39  
#40 
F1y: 
Malpighian 
tubules?                                            
F1#1+15+30                                                       
F1#36+39+4
0
  
24 pMC067: CaBeta-seq55 + seq 46-hs43-nGFP 
M7                                                                        
M7 jumps: #1  #13  #15  
#27  #34  #39  #46                                                                  
#46+39+34+2
7+11: 
epidermis?
067 
#46+39+34+
27+11  
  
NS pMC069:  CG10440-seq80 +89-hs43-nGFP F9, F10, M1, M2, M3, M4, M5, M6, M7, M8  
069 
M1+M2+M3 : 
nothing                                    
069 
M4+M5+M6 : 
idem 
M1 + M2+ 
M3:   
nothing                                   
M4 +M5 
+M6:  
nothing 
  
24 pMC071:Trim-seq129 + seq 138 -hs43-nGFP F4, F5, F6, F7, M1, M2, M3, M4 
M1+M2+M3: 
CNS after 
stg14                          
F4 +F5+F6: 
idem 
 M1+M2 
+M3: CNS 
after stg14   
F4 +F5+F6: 
CNS after 
stg14 
  
24 pMC073: betaTub97-seq58 + seq71-hs43-nGFP M1, M2, M3, M4, F5 
M1+M4: 
thoracic 
somatic 
mesoderm 
after stg13                     
M2+M3: idem 
M1 +M4: 
thoracic 
sMD after 
stg13          
M2 +M3: 
idem 
  
24 & 
25 pMC077: Ih-seq34-hs43-nGFP 
F9, F10, M1, M2, M3, 
M4, M5, M6, M7, M8,  
M1+M2+M3: 
nothing 
M4+M5+M6: 
idem 
M8+F9+F10: 
idem 
M2: weak 
heart                                                           
F10: weak 
heart 
  
24 & 
25 pMC078: Dms-seq5-hs43-nGFP 
F10, M1, M2, M3, M4, 
M5, M6, M7, M8,M9 
M1+M2+M3+
M4: nothing 
M5+M6+M7: 
idem 
M8+M9+F10:i
dem 
M1: weak 
heart                                                            
F10: heart  
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Solutions 
 
 BBS-250: 1x BBT, 250mM NaCl, 0,1% bovine serum 
 BBT-250: 1x BBT, 250mM NaCl 
 BBT: 1x PBS, 1% BSA, 0,05% Tween 20 
 Buffer 10´PBS: 80gr of NaCl, 11,5gr of Na2HPO4, 2gr of KH2PO4, 2gr of KCl, dH2O 
qsp 100ml. Adjust pH to 7,3-7,5 with HCl 10M. Autoclave. 
 Buffer 1xPBT: 100ml of 10xPBS (final concentration 1x), 1ml of Tween-20 (final 
(concentration final of 0,1%), dH2O qsp 1000ml.  
 Buffer 20xSSC: 175,3gr NaCl, 88,2gr NaCitrate, dH2O qsp 1000ml. Adjust pH to  7,0. 
with HCl 10M. First sterilize and then autoclave. 
 Fix buffer: 25ml of H2O, 5ml of 10´PBS, 100ml of EGTA 0,5M, 100ml MGSO4 1M  
 Fly food media : 170 ml of H2O, 95 gr of  agar, 940gr of sugar,  250gr yeast, 250ml corn 
flour.  
 Heparine: stock solution  50 mg/ml in buffer 4xSSC.  
 
 Hybe A (prehybridization solution): Final volume: 50 ml. 25 ml 100% formamide, 12,5 
ml 20x SSC, 12,5 ml of DEPC water  
 
 Hybe B (hybridization solution): Final volume: 100 ml . 50 ml 100% formamide, 25 ml 
20x SSC, 2 ml of 10 mg/ml Herring Sperm DNA, 500 ml 20 mg/ ml tRNA, 50 ml 100 
mg/ml  heparine,  DEPC water up to 100 ml. Store at -20°C 
 
 Molasse agar medium: mix 95ml mollase, 20g of agar 500ml of water. Autoclave, then 
transfer to water bath until the temperature goes down to 65°C. Add 16ml of ethanol 100 
% and 8ml of acetic acid and stir. Pour the media and stock at 4°C.  
 
 PBT: 1x PBS, 0,1% Tween-20 
 
 PTX: 1x PBS, 0,1% Triton-X-100  
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